Western Magnesium (MLYF) 10-Q 17 Mar 22 2022 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Jan. 31, 2022	Mar. 10, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jan. 31, 2022
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--10-31
Entity File Number	000-56323
Entity Registrant Name	WESTERN MAGNESIUM CORPORATION
Entity Central Index Key	0001801762
Entity Tax Identification Number	61-1934413
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	8180 Greensboro Drive
Entity Address, Address Line Two	Suite 720
Entity Address, City or Town	McLean
Entity Address, State or Province	VA
Entity Address, Postal Zip Code	22102
City Area Code	(571)
Local Phone Number	378-0762
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		425,747,452

Intermin Condensed Consolidated

Intermin Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Jan. 31, 2022	Oct. 31, 2021
Current assets
Cash	$ 772,522	$ 462,360
Amounts receivable	235,821	151,485
Prepayments	127,872	133,647
Deposits held by related parties	565,741	486,462
Total Current assets	1,701,956	1,233,954
Non-current assets
Property, plant and equipment	3,159,244	2,574,704
Right-of-use assets	533,093	598,575
Mineral property costs	93,453	93,453
Reclamation deposits	2,752	2,826
Other deposits	10,000	10,000
TOTAL ASSETS	5,500,498	4,513,512
Current liabilities
Accounts payable and accrued liabilities	2,552,509	1,989,316
Due to related parties	1,092,786	1,026,817
Lease obligations – current	220,309	192,045
Provision for flow through share issuances	227,140	233,285
Convertible debenture	221,599	7,449,807
Derivative liability	8,288,387
Total Current liabilities	12,602,730	10,891,270
Non-current liabilities
Lease obligations – non-current	320,045	392,280
Total liabilities	12,922,775	11,283,550
Shareholders’ deficit
Capital stock Authorized: 1 billion common stock at par value of $0.001 Issued and paid: 421,871,770 (2021 – 392,943,398)	36,637,228	29,842,167
Additional paid-in-capital	22,684,015	15,186,480
Obligations to issue shares	46,741	209,827
Accumulated other comprehensive income	285,889	121,109
Deficit	(67,076,150)	(52,129,621)
Total shareholders’ deficit	(7,422,277)	(6,770,038)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT	$ 5,500,498	$ 4,513,512

Intermin Condensed Consolidat_2

Intermin Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)	Jan. 31, 2022$ / sharesshares	Oct. 31, 2021$ / sharesshares
Statement of Financial Position [Abstract]
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, par value | (per share)	$ 0.001	$ 0.001
Common stock, shares issued	421,871,770	392,943,398
Common stock, shares outstanding	421,871,770	392,943,398

Interim Condensed Consolidated

Interim Condensed Consolidated Statements of Loss and Comprehensive Income (Unaudited) - USD ($)	3 Months Ended
	Jan. 31, 2022	Jan. 31, 2021
Expenses (recoveries)
Bank charges	$ 3,264	$ 2,562
Business development	45,552
Computer system and software	11,651	60,089
Consulting and management fees	197,927	67,101
Depreciation	109,340	51,326
Engineering expenses (recoveries)	118,373	(63,612)
Foreign exchange loss	167,474	49,920
Interest and accretion	322,280	18,574
Investor relations	106,378	51,876
Legal and professional fees	606,848	23,744
Office and general	56,080	37,454
Facilities and rent	63,669	15,085
Salaries and benefits	995,542	735,648
Stock-based compensation	131,575	1,048,990
Shareholder communications	33,201
Subsidies and recoveries	(31,102)
Transfer agent and regulatory fees	23,017	8,883
Travel expenses	84,116	836
Costs and Expenses	3,045,185	2,108,476
Other items
Change in fair value of derivative liabilities	(11,559,791)	(14,534)
Loss on recognition of debt host liability	(341,553)
Nonoperating Income (Expense)	(11,901,344)	(14,534)
Net loss for the period	(14,946,529)	(2,123,010)
Other comprehensive gain (loss)
Foreign currency translation	164,780	(87,762)
Comprehensive loss for the period	$ (14,781,749)	$ (2,210,772)
Basic and diluted loss per common share	$ (0.04)	$ (0.01)
Weighted average number of common shares outstanding – basic and diluted	410,834,167	329,203,182

Interim Condensed Consolidate_2

Interim Condensed Consolidated Statements of Shareholders' (Deficit) (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Obligation To Issue Shares [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Oct. 31, 2020	$ 21,322,022	$ 4,182,037	$ 596,872	$ 399,175	$ (28,580,009)	$ (2,079,903)
Beginning balance, shares at Oct. 31, 2020	323,419,527
Shares issued pursuant to private placements [note 13[b]]	$ 1,853,806		(596,872)			1,256,934
Shares issued pursuant to private placements, shares	18,319,388
Stock-based compensation [note 13[d]]		1,048,990				1,048,900
Foreign currency translation				(87,762)		(87,762)
Net loss for the period					(2,123,010)	(2,123,010)
Ending balance, value at Jan. 31, 2021	$ 23,175,828	5,231,027		311,413	(30,703,019)	(1,984,751)
Ending balance, shares at Jan. 31, 2021	341,738,915
Beginning balance, value at Oct. 31, 2020	$ 21,322,022	4,182,037	596,872	399,175	(28,580,009)	(2,079,903)
Beginning balance, shares at Oct. 31, 2020	323,419,527
Ending balance, value at Oct. 31, 2021	$ 29,842,167	15,186,480	209,827	121,109	(52,129,621)	(6,770,038)
Ending balance, shares at Oct. 31, 2021	392,943,398
Shares issued pursuant to private placements [note 13[b]]	$ 756,524		(209,827)			$ 546,697
Shares issued pursuant to private placements, shares	1,375,499
Shares issued on warrants exercised [notes 12[e] and 13[b]]	$ 5,774,998					$ 5,774,998
Shares issued on warrants exercised, shares	15,389,448
Shares issued for convertible debenture [notes 12[c] and 13[b]]	$ 300,000					300,000
Shares issued for convertible debenture, shares	3,000,000
Shares issued for finder’s fees [note 13[b]]
Shares issued for finder's fees shares	9,163,425
Share issue costs [note 13[b]]	$ (36,461)					(36,461)
Stock-based compensation [note 13[d]]		131,575				131,575
Effects of change in functional currency on convertible debentures [notes 12[d]]		7,370,159				7,370,159
Effects of change in functional currency on broker warrants [notes 12[e]]		(4,198)				(4,198)
Share subscriptions [note 13[f]]			46,741			46,741
Foreign currency translation				164,780		164,780
Net loss for the period					(14,946,529)	(14,946,529)
Ending balance, value at Jan. 31, 2022	$ 36,637,228	$ 22,684,015	$ 46,741	$ 285,889	$ (67,076,150)	$ (7,422,277)
Ending balance, shares at Jan. 31, 2022	421,871,770

Interim Condensed Consolidate_3

Interim Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Oct. 31, 2021
OPERATING ACTIVITIES
Net loss for the period	$ (14,946,529)	$ (2,123,010)
Add (subtract) items not affecting cash:
Accrued interest and accretion	9,773	10,803
Amortization of debt discount	300,034
Change in fair value of derivative liability	11,559,791	14,534
Loss on recognition of debt host liability	341,553
Depreciation of property, plant and equipment	50,434	4,039	$ 44,148
Depreciation of right-of-use assets	58,906	47,287	185,754
Foreign exchange loss	153,408	7,213
Interest expense on lease obligations	9,240	5,700
Stock-based compensation	131,575	1,048,990
Changes in non-cash working capital items relating to operations:
Amounts receivable	(88,738)	(13,694)
Prepayments	2,266	(12,380)
Deposits held by related parties	(92,521)
Accounts payable and accrued liabilities	619,673	19,196
Due to related parties	92,233	958
Cash used in operating activities	(1,798,902)	(990,364)
INVESTING ACTIVITIES
Purchase of property, plant and equipment	(687,385)	(167,559)
Cash used in investing activities	(687,385)	(167,559)
FINANCING ACTIVITIES
Proceeds from issuance of shares, net of share issuance costs	2,804,182	1,256,934
Proceeds from share subscriptions	46,741
Payments of promissory note		(27,202)
Payments of lease obligations	(46,636)	(49,310)
Cash provided by financing activities	2,804,287	1,180,422
Change in cash for the period	318,000	22,499
Cash, beginning of the period	462,360	39,571	39,571
Effect of foreign exchange on cash	(7,838)	1,320
Cash, end of the period	$ 772,522	$ 63,390	$ 462,360

NATURE OF OPERATIONS AND GOING

NATURE OF OPERATIONS AND GOING CONCERN	3 Months Ended
	Jan. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NATURE OF OPERATIONS AND GOING CONCERN	1. NATURE OF OPERATIONS AND GOING CONCERN Western Magnesium Corporation (the “Company”, or “WMC”) was incorporated under the laws of British Columbia on March 24, 1966. On May 14, 2019, the Company discontinued from the jurisdiction of the Business Corporations Act (British Columbia) and domesticated under the General Corporation Law of the State of Delaware under the name “Western Magnesium Corporation”. The Company is a reporting issuer in Canada and in the United States, listed for trading in Canada on the TSX Venture Exchange (the “TSX-V”) under the symbol “WMG.V”, in the United States on the OTCQB tier of the OTC Markets (the “OTCQB”) under the symbol “MLYF”, and in Germany on the Frankfurt Stock Exchange under the symbol “3WM”. The Company has developed proprietary magnesium production technology with the aim of becoming a premier low-cost producer of green primary magnesium metal. As at January 31, 2022, the Company had an accumulated deficit of $ 67,076,150 (October 31, 2021 – $ 52,129,621 ) and working capital deficiency of $ 10,900,774 (October 31, 2021 – $ 9,657,316 ). For the three months ended January 31, 2022, the Company reported a comprehensive loss of $ 14,781,749 (2021 – $ 2,210,772 ). The Company is considered to be in the development stage. It has not yet achieved profitable operations and expects to incur further losses in the development of its business. The Company has financed its activities and operations through equity issuances and debt financing and expects to continue to do so to the extent such instruments are issuable under terms acceptable to the Company and until such time as its operations provide positive cash flows. These unaudited condensed consolidated interim financial statements (the “Interim Financial Statements”) have been prepared under the assumption that the Company will continue as a going concern. The going concern basis of presentation assumes that the Company will be able to meet its obligations and continue its operations for the foreseeable future and be able to realize its assets and discharge its liabilities and commitments in the normal course of business. Management believes that the going concern assumption is appropriate for these Interim Financial Statements based on its continuing ability to raise financings through share and debt issuances. If future financing is unavailable or if for any reason the Company is unable to continue as a going concern, it could impact the Company’s ability to realize its assets at their recognized values and to meet its obligations in the ordinary course of business at the amounts stated in these Interim Financial Statements. These Interim Financial Statements do not give effect to adjustments that would be necessary to the carrying values and classifications of assets and liabilities should the Company be unable to continue as a going concern. If the going concern assumption is not used, the adjustments required to report the Company’s assets and liabilities on a liquidation basis could be material to these Interim Financial Statements. These factors indicate the existence of a material uncertainty that cast substantial doubt on the Company’s ability to continue as a going concern. In March 2020, the World Health Organization declared COVID-19 a global pandemic. In order to combat the spread of COVID-19, governments worldwide, including the Unites States and Canada, have enacted emergency measures including travel bans, legally enforced or self-imposed quarantine periods, social distancing and business and organization closures. These measures have adversely affected workforces, economies, and financial markets globally, leading to an economic downturn. The impact on the Company has not been significant but could affect the Company’s ability to raise financings in the future and restrict travel. Management continues to monitor the situation.

BASIS OF PRESENTATION

BASIS OF PRESENTATION	3 Months Ended
	Jan. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION	2. BASIS OF PRESENTATION These Interim Financial Statements comprise the financial statements of Western Magnesium Corporation and its wholly owned subsidiaries, Western Magnesium Corp., incorporated in Nevada, United States and Western Magnesium Canada Corporation, incorporated in British Columbia, Canada. [a] Accounting standards The accompanying Interim Financial Statements have been prepared by the Company in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) on the basis that the Company will continue as a going concern, which assumes that the Company will be able to meet its obligations and continue its operations for the next year. Realization values may be substantially different from carrying values as shown and these Financial Statements do not give effect to adjustments that would be necessary to the carrying values and classification of assets and liabilities should the Company be unable to continue as a going concern. These Interim Financial Statements have been prepared on a historical cost basis except for financial instruments that have been measured at fair value. In addition, these Interim Financial Statements have been prepared using the accrual basis of accounting, except for cash flow information. They do not include all the information required for full annual financial statements, and should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto for the year ended October 31, 2021 (the “Fiscal 2021 Financial Statements”). [b] Functional and presentation currency These Interim Financial Statements are presented in United States dollars (“US dollars” or “US$”), except where otherwise indicated. The functional currency of each entity of the Company is as follows: Entity Functional Currency Western Magnesium Corporation United States dollars Western Magnesium Corp. United States dollars Western Magnesium Canada Corporation Canadian dollars (“CA$”) During the period ended January 31, 2022, significant changes in economic facts and circumstances have occurred in Western Magnesium Corporation’s operations which resulted in the change of its functional currency to the United States dollars from the Canadian dollars effective November 1, 2021. For both monetary and non-monetary assets and liabilities, translated balances at the end of the prior period become the new accounting basis. The rate on the date of change becomes the historical rate at which non-monetary assets and liabilities are translated in subsequent years. There is no effect on the cumulative translation adjustment on the consolidated basis. Previously recorded cumulative translation adjustments are not reversed. Effects of change in functional currency included the reclassifications of convertible debentures and warrants and broker warrants [notes 12[d] and [e]] The accounts of the Company’s subsidiary Western Magnesium Canada Corporation have been translated to United States dollars. [c] Critical accounting estimates and judgments Significant Estimates and Assumptions The preparation of these Interim Financial Statements in accordance with US GAAP requires the Company to make estimates and assumptions concerning the future. Management reviews these estimates and underlying assumptions on an ongoing basis, based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Revisions to estimates are adjusted for prospectively in the period in which the estimates are revised. Estimates and assumptions where there is potential risk of material adjustments to assets and liabilities in future accounting periods include the useful lives of property, plant and equipment, recoverability of the carrying value of exploration and evaluation assets, fair value measurements for financial instruments, discount rates for leases, recoverability and measurement of deferred tax assets and liabilities, and contingent liabilities. Significant Judgments The preparation of these Interim Financial Statements in accordance with US GAAP requires the Company to make judgments, apart from those involving estimates, in applying accounting policies. The most significant judgments in applying the Company’s Interim Financial Statements include: - the assessment of the Company’s ability to continue as a going concern and whether there are events or conditions that may give rise to substantial doubt; - whether there are indicators of impairment of the Company’s exploration and evaluation assets and other non-current assets; - the classification of financial instruments; and - determination of functional currency.

RECENT ACCOUNTING PRONOUNCEMENT

RECENT ACCOUNTING PRONOUNCEMENTS	3 Months Ended
	Jan. 31, 2022
Accounting Changes and Error Corrections [Abstract]
RECENT ACCOUNTING PRONOUNCEMENTS	3. RECENT ACCOUNTING PRONOUNCEMENTS New Accounting Standards Adopted During the Periods In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. ASU 2019-12 is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, with early adoption permitted. Effective November 1, 2021, the Company adopted the new standard. There was no material impact or adjustment to these Interim Financial Statements. In January 2020, the FASB issued ASU 2020-01, Investments – Equity Securities (Topic 321), Investments – Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (“ASU 2020-01”), which is intended to clarify the interactions of the accounting for equity securities under Topic 321 and investments accounted for under the equity method of accounting in Topic 323 and the accounting for certain forward contracts and purchased options accounted for under Topic 815. ASU 2020-01 is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, with early adoption permitted. Effective November 1, 2021, the Company adopted the new standard. There was no material impact or adjustment to these Interim Financial Statements. New Accounting Standards Not Yet Adopted In August 2020, the FASB issued ASU 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”). ASU 2020-06 eliminates the beneficial conversion and cash conversion accounting models for convertible instruments and supersedes the respective guidance within ASC 470-20 and ASC 740-10-55-51, which will result in more instruments to be accounted for as a single instrument rather than having their proceeds allocated between liability and equity accounting units. As smaller reporting companies as defined by the United States Securities and Exchange Commission (the “SEC”), ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the effect of adopting these updates on its financial statements.

PROPERTY, PLANT AND EQUIPMENT

PROPERTY, PLANT AND EQUIPMENT	3 Months Ended
	Jan. 31, 2022
Property, Plant and Equipment [Abstract]
PROPERTY, PLANT AND EQUIPMENT	4. PROPERTY, PLANT AND EQUIPMENT SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT Computer Equipment Furniture Leasehold Improvement Furnace & Plant Equipment Vehicle Total $ $ $ $ $ $ Cost Balance, October 31, 2020 32,318 38,916 7,610 28,413 – 107,257 Additions 77,955 11,510 129,257 2,278,205 – 2,496,927 Write-off of equipment (4,245 ) – – – – (4,245 ) Foreign exchange effect 3,601 3,116 2,614 38,108 – 47,439 Balance, October 31, 2021 109,629 53,542 139,481 2,344,726 – 2,647,378 Cost, Beginning Balance 109,629 53,542 139,481 2,344,726 – 2,647,378 Additions – 2,171 21,932 634,067 29,215 687,385 Foreign exchange effect – (230 ) (3,611 ) (49,144 ) (136 ) (53,121 ) Balance, January 31, 2022 109,629 53,483 157,802 2,929,649 29,079 3,281,642 Cost, Ending Balance 109,629 53,483 157,802 2,929,649 29,079 3,281,642 Accumulated Depreciation Balance, October 31, 2020 14,677 8,326 4,818 – – 27,821 Depreciation expense 13,907 7,443 8,827 13,971 – 44,148 Write-off of equipment (2,057 ) – – – – (2,057 ) Foreign exchange effect 1,294 745 502 221 – 2,762 Balance, October 31, 2021 27,821 16,514 14,147 14,192 – 72,674 Accumulated Depreciation, Beginning Balance 27,821 16,514 14,147 14,192 – 72,674 Depreciation expense 8,794 1,880 4,656 34,374 730 50,434 Foreign exchange effect – (35 ) (230 ) (442 ) (3 ) (710 ) Balance, January 31, 2022 36,615 18,359 18,573 48,124 727 122,398 Accumulated Depreciation, Ending Balance 36,615 18,359 18,573 48,124 727 122,398 Net Book Value Balance, October 31, 2020 17,641 30,590 2,792 28,413 – 79,436 Balance, October 31, 2021 81,808 37,028 125,334 2,330,534 – 2,574,704 Balance, January 31, 2022 73,014 37,124 139,229 2,881,525 28,352 3,159,244

RIGHT-OF-USE ASSETS

RIGHT-OF-USE ASSETS	3 Months Ended
	Jan. 31, 2022
Right-of-use Assets
RIGHT-OF-USE ASSETS	5. RIGHT-OF-USE ASSETS As at January 31, 2022, the right-of-use assets are leases for the Company’s corporate offices in Vancouver, British Columbia and McLean, Virginia, and its research and development pilot plant located in Burnaby, British Columbia. These leases terminate on March 31, 2023, February 28, 2025 and September 30, 2023, respectively. The lease for the Company’s office in Las Vegas, Nevada ended on May 31, 2021. SCHEDULE OF RIGHT-OF-USE ASSETS Vancouver Office Virginia Office Nevada Office Pilot Plant Total $ $ $ $ $ Cost Balance, October 31, 2020 59,701 – 22,856 357,949 440,506 Additions 91,237 287,847 – – 379,084 Foreign exchange effect 5,943 4,544 1,724 26,997 39,208 Balance, October 31, 2021 156,881 292,391 24,580 384,946 858,798 Cost, beginning balance 156,881 292,391 24,580 384,946 858,798 Foreign exchange effect – – – (10,139 ) (10,139 ) Balance, January 31, 2022 156,881 292,391 24,580 374,807 848,659 Cost, ending balance 156,881 292,391 24,580 374,807 848,659 Accumulated Depreciation Balance, October 31, 2020 42,142 – 14,434 9,943 66,519 Depreciation expense 44,259 15,288 8,915 117,292 185,754 Foreign exchange effect 3,876 241 1,231 2,602 7,950 Balance, October 31, 2021 90,277 15,529 24,580 129,837 260,223 Accumulated depreciation, beginning balance 90,277 15,529 24,580 129,837 260,223 Depreciation expense 11,021 16,935 – 30,950 58,906 Foreign exchange effect – – – (3,563 ) (3,563 ) Balance, January 31, 2022 101,298 32,464 24,580 157,224 315,566 Accumulated depreciation, ending balance 101,298 32,464 24,580 157,224 315,566 Net Book Value Balance, October 31, 2020 17,559 – 8,422 348,006 373,987 Balance, October 31, 2021 66,604 276,862 – 255,109 598,575 Balance, January 31, 2022 55,583 259,927 – 217,583 533,093

LEASE OBLIGATIONS

LEASE OBLIGATIONS	3 Months Ended
	Jan. 31, 2022
Lease Obligations
LEASE OBLIGATIONS	6. LEASE OBLIGATIONS On adoption of ASU 2016-02 on November 1, 2019, the Company recognized lease liabilities of $ 83,549 7 During the year ended October 31, 2020, the Company entered into a new operating lease with respect to its research and development pilot plant located in Burnaby, British Columbia and recognized a lease liability of $ 354,263 6 During the year ended October 31, 2021, the Company renewed its operating lease with respect to its corporate office in Vancouver, British Columbia and recognized a lease liability of $ 91,237 7 During the year ended October 31, 2021, the Company entered into a new operating lease with respect to its office in McLean, Virginia and recognized a lease liability of $ 260,649 7 SCHEDULE OF OPERATING LEASE Vancouver Office Virginia Office Nevada Office Pilot Plant Total $ $ $ $ $ Balance, October 31, 2020 18,123 – 12,211 350,593 380,927 Additions 91,237 260,649 – – 351,886 Lease payments (47,931 ) (5,137 ) (9,457 ) (139,037 ) (201,562 ) Interest expenses 3,076 3,019 219 19,005 25,319 Prior period adjustment – – (3,065 ) – (3,065 ) Foreign exchange effect 2,099 4,081 92 24,548 30,820 Balance, October 31, 2021 66,604 262,612 – 255,109 584,325 Operating lease liability, beginning balance 66,604 262,612 – 255,109 584,325 Lease payments (12,097 ) – – (34,538 ) (46,635 ) Interest expenses 1,076 4,575 – 3,589 9,240 Foreign exchange effect – – – (6,576 ) (6,576 ) Balance, January 31, 2022 55,583 267,187 – 217,584 540,354 Operating lease liability, ending balance 55,583 267,187 – 217,584 540,354 Which consist of: Current lease obligation 47,548 44,823 – 127,938 220,309 Non-current lease obligation 8,035 222,364 – 89,646 320,045 Balance, January 31, 2022 55,583 267,187 – 217,584 540,354 Operating lease liability, ending balance 55,583 267,187 – 217,584 540,354

MINERAL PROPERTY COSTS

MINERAL PROPERTY COSTS	3 Months Ended
	Jan. 31, 2022
Extractive Industries [Abstract]
MINERAL PROPERTY COSTS	7. MINERAL PROPERTY COSTS As at January 31, 2022, the Company had the following mining claims: [a] Silverado Property Nevada, United States The Silverado property is located in the Pinto mining district of Nevada, consists of 3 patented mining claims totaling approximately 120 100 1 [b] Tami Mosi Property, Nevada, United States The Company holds a 100 1,637 10 2 93,452

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended
	Jan. 31, 2022
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	8. RELATED PARTY TRANSACTIONS [a] Deposits held by related parties The Company provided related parties with advances that were held as deposits for anticipated future costs related to the Company’s planned magnesium research and development pilot plant and other administrative expenses (the “Pilot Plant Advances”). As at January 31, 2022, the Company had the following deposits held by related parties: SCHEDULE OF DEPOSITS HELD BY RELATED PARTY Related Party A [i] Related Party B [ii] Total $ $ $ Balance, October 31, 2020 – – – Advances 987,912 2,292,912 3,280,824 Costs and expenses (696,431 ) (2,097,931 ) (2,794,362 ) Balance, October 31, 2021 291,481 194,981 486,462 Advances 300,000 522,335 822,335 Costs and expenses (79,793 ) (675,390 ) (755,183 ) Foreign exchange effect 13,193 (1,066 ) 12,127 Balance, January 31, 2022 524,881 40,860 565,741 [i] Related Party A is a company controlled by a director and officer. [ii] Related Party B is a company controlled by an officer. [b] Due to related parties As at January 31, 2022, balances due to related parties totaled $ 1,092,786 1,026,817 SCHEDULE OF DUE TO RELATED PARTIES January 31, 2022 October 31, 2021 $ $ Wages payable to directors and officers 357,500 357,500 Benefits payable to directors and officers 581,854 539,209 Fees and expenses payable to directors and officers 151,261 127,878 Interests due to a shareholder 2,171 2,230 Total 1,092,786 1,026,817 [c] Key management compensation As at January 31, 2022, the Company had twelve executives including eight in senior management. Their aggregate annualized compensation is approximately $ 2.9 747,589 [d] Transactions with related parties [i] During the three months ended January 31, 2022, the Company incurred consulting fees of CA$ 30,000 23,587 [ii] In June 2021, the Company renewed its sublease agreement with a company controlled by a director and officer for its corporate office in Vancouver, British Columbia with a lease term from April 1, 2021 to March 31, 2023 at a monthly rent of CA$ 9,794 7,700 [iii] Pursuant to an agreement entered on August 29, 2018 and which was approved by the TSX-V on September 12, 2018, a company controlled by a director and officer is eligible to receive up to 5 5 9,163,425 0.65 5,956,226 4,796,832

CONTINGENT LIABILITIES AND COMM

CONTINGENT LIABILITIES AND COMMITMENTS	3 Months Ended
	Jan. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
CONTINGENT LIABILITIES AND COMMITMENTS	9. CONTINGENT LIABILITIES AND COMMITMENTS [a] Contingent liabilities [i] On September 29, 2020, James Sever filed a Notice of Civil Claim against the Company in the Supreme Court of British Columbia (the “Sever Claim”). The Sever Claim alleges that Mr. Sever had an employment and/or other similar contractual relationship with the Company, and that the Company breached such contractual relationship by way of constructive dismissal or similar conduct. The Sever Claim seeks damages in excess of $ 2.5 [ii] On December 31, 2020, GEM Yield Bahamas Limited (“GEM”) served the Company with a Notice of Intention to Arbitrate (the “New York Arbitration Notice”) before the American Arbitration Association in New York (the “GEM New York Arbitration”). The New York Arbitration Notice alleges the Company breached a Share Subscription Agreement dated November 15, 2019 entered into between the Company and GEM (the “GEM Agreement”), among other things, claiming damages of CA$ 4.2 3.4 [iii] On February 8, 2021, GEM instituted another arbitration against the Company before the International Centre for Dispute Resolution in Montreal Canada (the “GEM Montreal Arbitration”) and joined GEM’s affiliate, GEM Global Yield LLC SCS (“GEM Global Yield” together with GEM, the “GEM Parties”). The Statement of Claim filed by the GEM Parties alleges the Company breached a Share Subscription Agreement dated November 15, 2019 and promissory note, among other things, claiming damages of approximately CA$ 4.9 3.9 33 [iv] On April 19, 2021, Lampert Advisors, LLC (“Lampert”) filed a Verified Complaint against the Company’s wholly owned subsidiary Western Magnesium Corp., a Nevada corporation (“Western Magnesium – Nevada”) in the Supreme Court of the State of New York, County of New York (the “Lampert Lawsuit”). The complaint filed in the Lampert Lawsuit alleges that Lampert entered into an agreement with Western Magnesium – Nevada to provide various financial advisory services including acquisition advisory services and act as an exclusive placement agent for a combination of debt and equity securities (the “Lampert Agreement”), that it performed all services required under that agreement and that it is owed $ 367,227 9 [b] Commitments [i] On November 1, 2016, the Company signed a contract services agreement with Lodestar Management Group, LLC (“Lodestar”), a US corporate logistics company. Lodestar provides advisory, consulting, negotiation and other management services relating to corporate management, administrative and/or operational activities of the Company. The term of the contract was for one year and has been renewed under the same terms on January 1, 2018 and 2019. The Company has agreed to compensate Lodestar in the amount of $ 1,800 2,500 0.05 1,800 2,500 nil nil 53,491 53,491 [ii] During the year ended October 31, 2020, the Company has entered into a lease agreement for its research and development pilot plant in Burnaby, British Columbia with a lease term from October 1, 2020 to September 30, 2023 at a monthly rent of CA$ 20,715 16,727 9,794 7,909 9,113 41,010 [notes 5 and 6]

PROMISSORY NOTE

PROMISSORY NOTE	3 Months Ended
	Jan. 31, 2022
Promissory Note
PROMISSORY NOTE	10. PROMISSORY NOTE During the year ended October 31, 2019, the Company received a loan of CA$ 150,000 112,895 18 60,000 44,588 210,000 157,483 1,639 16,655 65,761 101,066

PROVISION FOR FLOW THROUGH SHAR

PROVISION FOR FLOW THROUGH SHARE ISSUANCES	3 Months Ended
	Jan. 31, 2022
Provision For Flow Through Share Issuances
PROVISION FOR FLOW THROUGH SHARE ISSUANCES	11. PROVISION FOR FLOW THROUGH SHARE ISSUANCES The Company has recorded a provision in the amount of $ 227,140 233,285

CONVERTIBLE DEBENTURE AND DERIV

CONVERTIBLE DEBENTURE AND DERIVATIVE LIABILITY	3 Months Ended
	Jan. 31, 2022
Debt Disclosure [Abstract]
CONVERTIBLE DEBENTURE AND DERIVATIVE LIABILITY	12. CONVERTIBLE DEBENTURE AND DERIVATIVE LIABILITY [a] July 2020 Convertible Debenture On July 27, 2020, the Company closed a non-brokered private placement of an unsecured convertible note in the principal amount of CA$ 150,000 112,124 12 0.15 1,360,959 263,973 26,286 37 [b] July 2021 Convertible Debenture On July 15, 2021, the Company closed a non-brokered private placement of an unsecured convertible note in the principal amount of CA$ 100,000 79,542 12 0.12 0.20 As at January 31, 2022, the Company incurred contractual interest of CA$ 9,337 7,375 7,299 5,802 effective interest rate of 608.98% [c] June 2021 Convertible Debenture On June 15, 2021, the Company closed a non-brokered private placement of an unsecured convertible note in the principal amount of $ 1,500,000 12 December 10, 2022 15,000,000 (i) one share of the Company’ common stock, (ii) one-half of one Class A common stock purchase warrant, with each whole warrant being exercisable at a price of $0.13 until June 10, 2026, and (iii) one-half of one Class B common stock purchase warrant, with each whole warrant being exercisable at a price of $0.19 until June 10, 2026 (collectively, the “Class A and B Warrants”). In addition, the conversion price for accrued interest is the greater of (i) $0.10 and (ii) the minimum conversion price permitted by the TSX-V at the time of conversion As part of the offering of the June 2021 Convertible Debenture, the Company also entered into the June 10, 2021 Securities Purchase Agreement (the “Securities Purchase Agreement”), whereby the Company agreed to use commercially reasonable efforts to file a registration statement with the United States Securities and Exchange Commission (the “SEC”) by August 14, 2021, covering the public resale of the shares of common stock underlying such debenture and, upon its conversion, the Class A and B Warrants issuable upon such conversion (the “Underlying Shares”), and to use its best efforts to cause the registration statement to be declared effective on October 13, 2021. On December 13, 2021, the Company’s Form 10 Registration Statement filed with the SEC was declared effective. In addition to certain covenants contained in the Securities Purchase Agreement, the terms of the June 2021 Convertible Debenture contain certain negative covenants by the Company, including, among others, sell or offer to sell any securities with non-fixed or floating price features, issue any common stock or common stock equivalents at a price lower than the Conversion Price herein then in effect, or issue any equity or debt instruments with anti-dilution provisions. In the event the Company issues or sells any common stock or common stock equivalents with terms that the purchaser holding the outstanding June 2021 Convertible Debenture (the “Convertible Debenture Holder”) or the Class A and B Warrants reasonably believes are more favorable to such holder than the terms of the June 2021 Convertible Debenture or the Class A and B Warrants, then upon notice to the Company by such holder within five trading days after notice to such holder by the Company, the Company will use commercially reasonable efforts to obtain the approval of the TSX-V and any additional required regulatory approval to amend the terms of the June 2021 Convertible Debenture or the Class A and B Warrants as required, as the case may be, so as to give such holder the benefit of such more favorable terms or conditions. The conversion price of the June 2021 Convertible Debenture and the exercise price of the Class A and B Warrants are subject to proportional adjustment in the event of stock splits, stock dividends and similar corporate events, including merger or consolidation of the Company or in a “Fundamental Transaction” as defined in the June 2021 Convertible Debenture. The Company has granted the holders certain rights of first refusal on its future offerings for as long as the June 2021 Convertible Debenture or the Class A and B Warrants are outstanding. The Company may prepay and satisfy the June 2021 Convertible Debenture so long as an event of default has not occurred, upon 20 days’ prior written notice received by the Company to the holder, by paying 125% of the amounts owed on the June 2021 Convertible Debenture, including all principal, interest and other fees. The holder of this debenture may, however, convert all or a portion of the debenture during the 20-day notice period. During the three months ended January 31, 2022, the Company issued an aggregate 3,000,000 3,000,000 1,500,000 0.13 1,500,000 0.19 [note 13[b]] As at January 31, 2022, the Company incurred contractual interest of $ 109,808 70,521 effective interest rate of 1,348% [d] Debt Host Liability and Embedded Derivative Liability Certain of the Company’s convertible debentures were determined to be hybrid financial instruments comprised of a debt host liability and an embedded derivative liability, as under the conversion feature the number of shares that will or may be issued to settle the notes may vary. The Company uses the Black-Scholes Option Pricing Model based on different default risks and assumptions. The debt host liability of the convertible note will be measured at amortized cost, with the embedded derivative liability measured at fair value through profit and loss. On issuance date of the July 2020 Convertible Debenture, the fair value of its debt host liability was determined to be $ 87,083 25,041 On issuance date of the June 2021 Convertible Debenture, it was determined to be a hybrid financial instrument comprised of a debt host liability and an embedded derivative liability. The embedded derivative liability was valued at $ 1,646,600 1,500,000 1 146,601 7,449,744 300,034 1,199,966 On issuance date of the July 2021 Convertible Debenture, it was determined to be a convertible debt instrument with a beneficial conversion feature accounted for in accordance with ASU 470-20. The Company allocated the intrinsic value of the beneficial conversion feature of the July 2021 Convertible Debenture capped at the face value of CA$ 100,000 79,542 529,400 421,095 429,400 341,553 11,780 9,262 269,300 211,730 281,080 220,992 The inputs used in the Black-Scholes Option Pricing Model are as follows: SCHEDULE OF OPTION PRICING MODEL January 31, November 1, October 31, June 15, July 27, 2022 2021 2021 2021 2020 Risk free rate of interest 1.51 % 1.07 % 1.08 % 0.31 % 0.26 % Expected life in years 0.45 0.70 1.11 1.50 0.74 Conversion exercise price CA$ 0.12 CA$ 0.12 $ 0.10 $ 0.10 CA$ 0.15 Underlying share price of the Company CA$ 0.44 CA$ 0.75 $ 0.59 $ 0.19 CA$ 0.13 Expected volatility 109.11 % 124.34 % 107.62 % 87.17 % 82.54 % Expected dividend rate Nil Nil Nil Nil Nil SCHEDULE OF DERIVATIVE INSTRUMENTS July 2020 Convertible Debenture June 2021 Convertible Debenture July 2021 Convertible Debenture Total $ $ $ $ Debt Host Liability Balance, October 31, 2020 96,318 – – 96,318 Value of debt host liability recognized – 1 – 1 Accretion and interest expense 23,587 43 63 23,693 Conversion (125,560 ) – – (125,560 ) Foreign currency translation 5,655 – – 5,655 Balance, October 31, 2021 – 44 63 107 Effects of change in functional currency – 1,500,000 – 1,500,000 Accretion and interest expense – 529 9,244 9,773 Conversion – (300,000 ) – (300,000 ) Foreign currency translation – – (45 ) (45 ) Balance, January 31, 2022 – 1,200,573 9,262 1,209,835 Embedded Derivative Liability Balance, October 31, 2020 20,123 – – 20,123 Fair value of embedded derivative liability recognized – 1,646,600 – 1,646,600 Fair value adjustment (16,058 ) 5,717,328 – 5,701,270 Conversion (5,247 ) – – (5,247 ) Foreign currency translation 1,182 85,772 – 86,954 Balance, October 31, 2021 – 7,449,700 – 7,449,700 Effects of change in functional currency – (7,449,700 ) 421,094 (7,028,606 ) Fair value adjustment – – (205,450 ) (205,450 ) Foreign currency translation – – (3,914 ) (3,914 ) Balance, January 31, 2022 – – 211,730 211,730 Debt Discount Balance, October 31, 2021 – – – – Effects of change in functional currency – (1,500,000 ) – (1,500,000 ) Amortization – 300,034 – 300,034 Balance, January 31, 2022 – (1,199,966 ) – (1,199,966 ) Combined Value of Convertible Debenture Balance, October 31, 2020 116,441 – – 116,441 Balance, October 31, 2021 – 7,449,744 63 7,449,807 Balance, January 31, 2022 – 607 220,992 221,599 [e] Derivative Liability – Warrants and Broker Warrants On November 1, 2021, the Company’s functional currency change resulted in the reclassification of its outstanding warrants and broker warrants denominated in the Canadian dollars as derivative liabilities measured at fair value through profit and loss. The previous value of outstanding broker warrants was reversed out of additional paid-in capital, and the derivative liability of warrants and broker warrants were valued at $ 26,956,177 and $ 76,811 , respectively. During the three months ended January 31, 2022, upon exercise of common share purchase warrants, a value of $ 3,481,052 was reclassified from derivative liability to share capital. As at January 31, 2022, the derivative liability of warrants and broker warrants were valued at $ 8,246,718 and $ 41,670 , respectively, resulting in a net loss in the quarter of $ 11,765,241 The Company uses the Black-Scholes Option Pricing Model based on default risks and assumptions as appropriate.

SHARE CAPITAL

SHARE CAPITAL	3 Months Ended
	Jan. 31, 2022
Equity [Abstract]
SHARE CAPITAL	13. SHARE CAPITAL [a] Authorized capital The authorized share capital consists of 1,000,000,000 0.001 [b] Common shares issued Fiscal 2021 [i] In connection with the non-brokered private placement announced on September 10, 2020: On November 20, 2020, the Company closed the first tranche of the non-brokered private placement, issuing 5,599,171 0.13 727,892 556,876 On January 15, 2021, the Company closed the second tranche of the non-brokered private placement, consisting of 7,337,914 0.13 953,930 749,435 39,996 On January 29, 2021, the Company closed the third tranche of the non-brokered private placement consisting of 5,382,303 0.13 699,699 547,496 On March 24, 2021, the Company closed the fourth tranche of the non-brokered private placement consisting of 6,554,172 0.13 852,042 678,270 On April 27, 2021, the Company closed the fifth and final tranche of the non-brokered private placement consisting of 851,395 0.13 110,681 89,237 In total, the Company issued an aggregate 25,724,955 0.13 3,344,244 2,621,314 Each unit issued consists of one common share and one common share purchase warrant entitling the holder to acquire a further common share at a price of CA$0.19 for a period of one year from the closing date of the respective financing tranche 195,614 [ii] On May 5, 2021, the Company announced a non-brokered private placement priced at CA$ 0.13 3,000,000 5,223,420 0.13 679,044 561,844 17,853,506 0.13 2,320,956 1,880,687 23,076,926 0.13 3,000,000 2,442,531 Each unit issued consists of one common share and one common share purchase warrant entitling the holder thereof to acquire a further common share at a price of CA$0.19 for a period of one year from the date of closing of the respective financing tranche 154,336 [iii] On May 18, 2021, the Company issued a total of 1,360,959 263,973 26,286 [iv] On June 7, 2021, the Company issued 1,538,461 0.24 369,231 305,832 [v] On July 16, 2021, the Company closed a non-brokered private placement and issued 4,350,000 0.20 870,000 690,860 Each unit consists of one common share and one common share purchase warrant entitling the holder thereof to acquire a further common share at a price of CA$0.30 for a period of one year from the date of closing 48,319 [vi] On August 11, 2021, the Company closed a non-brokered private placement and issued 3,827,601 0.55 0.44 2,105,180 1,683,336 Each unit consists of one common share and one common share purchase warrant entitling the holder thereof to acquire a further common share at a price of CA$0.65 (US$0.52) for a period of eighteen months from the date of closing 124,923 [vii] During the year ended October 31, 2021, the Company issued a total of 7,014,969 0.05 0.21 1,120,130 887,520 525,173 [viii] During the year ended October 31, 2021, the Company issued a total of 2,630,000 0.05 0.16 175,800 140,734 [ix] With respect to the exercises of common share purchase warrants and options, the Company reclassified $ 4,291 and $ 121,932 , respectively, from additional paid-in capital to share capital during the year ended October 31, 2021. Fiscal 2022 [i] Pursuant to an agreement entered on August 29, 2018 and which was approved by the TSX-V on September 12, 2018, a company controlled by a director and officer was eligible to receive up to 5% of the issued and outstanding common shares of the Company as at August 28, 2018 for up to $ 5 9,163,425 0.65 5,956,226 4,796,832 [ii] On November 4, 2021, the Company issued 1,000,000 units on partial conversion of the June 2021 Convertible Debenture, for a total of 1,000,000 common shares, 500,000 Class A Warrants exercisable at a price of $ 0.13 until June 10, 2026, and 500,000 Class B Warrants exercisable at a price of $ 0.19 until June 10, 2026. On December 13, 2021, the Company issued a further 1,000,000 units on partial conversion of the June 2021 Convertible Debenture, for a total of 1,000,000 common shares, 500,000 Class A Warrants exercisable at a price of $ 0.13 until June 10, 2026, and 500,000 Class B Warrants exercisable at a price of $ 0.19 until June 10, 2026. On January 20, 2022, the Company issued a further 1,000,000 units on partial conversion of the June 2021 Convertible Debenture, for a total of 1,000,000 common shares, 500,000 Class A Warrants exercisable at a price of $ 0.13 until June 10, 2026, and 500,000 Class B Warrants exercisable at a price of $ 0.19 until June 10, 2026. The Company incurred aggregate share issue costs of $ 1,361 . [iii] On November 26, 2021, the Company closed a non-brokered private placement and issued 1,375,499 0.55 756,524 0.75 26,656 [iv] During the three months ended January 31, 2022, upon exercise of common share purchase warrants, the Company issued an aggregate 15,159,448 0.19 2,880,295 2,279,136 200,000 0.05 10,000 7,830 30,000 0.30 9,000 6,981 15,389,448 2,899,295 2,293,946 2,428,363 [c] Common share purchase warrants A summary of the changes in the Company’s common share purchase warrants during the three months ended January 31, 2022 are as follows: SUMMARY OF CHANGES IN COMMON SHARE PURCHASE WARRANTS Expiry Date Exercise Price Weighted Average Life (Years) October 31, 2021 Granted Exercised Expired/ Cancelled January 31, 2022 Expiry Date Exercise Price Weighted Average Life (Years) October 31, 2021 Granted Exercised Expired/ Cancelled January 31, 2022 November 22, 2021 CA$ 0.19 – 4,160,021 – (4,080,573 ) (79,448 ) – January 17, 2022 CA$ 0.19 – 7,267,914 – (5,959,396 ) (1,308,518 ) – January 31, 2022 CA$ 0.19 – 5,382,303 – (4,341,906 ) (1,040,397 ) – February 21, 2022 CA$ 0.05 0.06 1,505,200 – – – 1,505,200 March 24, 2022 CA$ 0.19 0.14 6,341,872 – (570,046 ) – 5,771,826 March 27, 2022 CA$ 0.05 0.15 982,025 – – – 982,025 April 27, 2022 CA$ 0.19 0.24 791,395 – (50,000 ) – 741,395 May 9, 2022 CA$ 0.05 0.27 1,813,725 – – – 1,813,725 May 30, 2022 CA$ 0.19 0.33 5,223,420 – (47,527 ) – 5,175,893 June 17, 2022 CA$ 0.19 0.38 17,703,506 – (110,000 ) – 17,593,506 July 18, 2022 CA$ 0.30 0.46 4,350,000 – (30,000 ) – 4,320,000 August 14, 2022 CA$ 0.05 0.53 200,000 – (200,000 ) – – February 13, 2023 CA$ 0.65 1.04 3,827,601 – – – 3,827,601 Subtotal 59,548,982 – (15,389,448 ) (2,428,363 ) 41,731,171 Weighted average exercise price CA$ 0.22 – CA$ 0.19 CA$ 0.19 CA$ 0.23 November 27, 2022 US$ 0.75 0.82 – 1,375,499 – – 1,375,499 June 10, 2026 US$ 0.13 4.36 – 1,500,000 – – 1,500,000 June 10, 2026 US$ 0.19 4.36 – 1,500,000 – – 1,500,000 Subtotal – 4,375,499 – – 4,375,499 Weighted average exercise price – US$ 0.35 – – US$ 0.35 Total 59,548,982 4,375,499 (15,389,448 ) (2,428,363 ) 46,106,670 A summary of the changes in the Company’s common share purchase warrants during the three months ended January 31, 2021 are as follows: Expiry Date Exercise Price ($) Weighted Average Life (Years) October 31, 2020 Granted Exercised Expired/ Cancelled January 31, 2021 Expiry Date Exercise Price Weighted Average Life (Years) October 31, 2020 Granted Exercised Expired/ Cancelled January 31, 2021 August 31, 2021 * CA$ 0.21 0.58 3,643,791 - – – 3,643,791 November 22, 2021 CA$0.19 0.80 – 5,599,171 – – 5,599,171 January 17, 2022 CA$0.19 0.96 – 7,337,914 – – 7,337,914 January 31, 2022 CA$0.19 0.99 – 5,382,303 – – 5,382,303 February 21, 2022 CA$0.05 1.06 1,505,200 – – – 1,505,200 March 27, 2022 CA$0.05 1.15 1,482,025 – – – 1,482,025 May 9, 2022 CA$0.05 1.27 2,368,626 – – – 2,368,626 August 14, 2022 CA$0.05 1.53 1,110,000 – – – 1,110,000 Total 10,109,642 18,319,388 – – 28,429,030 Weighted average exercise price CA$ 0.11 CA$ 0.19 – – CA$ 0.16 * The Company received approval of the TSX-V on January 13, 2021 and amended the expiry date of 3,643,791 extending the expiry date from January 17, 2021 to August 31, 2021 0.30 10 [d] Stock options The Company has adopted an incentive stock option plan, effective on August 8, 2017 and as amended on August 8, 2018, under the rules of the TSX-V pursuant to which it is authorized to grant stock options to executive officers, directors, employees and consultants, enabling them to acquire up to 20 Stock options granted are subject to a maximum term of 5 years. All options granted shall vest immediately, except for those options granted to persons performing investor relations activities for the Company On June 11, 2021, the Company adopted the 2021 Equity Incentive Plan which replaces the 2017 Stock Option for providing stock-based compensation to directors, officers, employees, consultants, and advisors of the Company and no further options will be granted under the 2017 Stock Option Plan. Under the 2021 Equity Incentive Plan, the Company is authorized to issue up 27,312,368 3,730,000 1,730,000 On December 30, 2020, the Company granted 15,650,000 0.13 9,500,000 6,150,000 On August 30, 2021, the Company granted 21,700,000 0.70 five years On October 1, 2021, the Company granted 1,450,000 0.50 five years On December 3, 2021, the Company granted 250,000 0.58 five years As at January 31, 2022, the maximum number of common shares available under the 2021 Equity Incentive Plan was 31,042,368 7,642,368 During the three months January 31, 2022, the Company recognized a stock-based compensation totaling $ 131,575 1,048,990 The weighted average grant date fair value of the stock options granted during the three months ended January 31, 2022 was CA$ 0.50 0.09 SCHEDULE OF ASSUMPTIONS USED 2022 2021 Risk free rate of interest 1.34 % 0.20 1.07 Expected life of options 5 2 5 Exercise price of options CA$ 0.58 CA$ 0.13 0.70 Expected annualized volatility 136.08 % 130.88 140.05 Expected dividend rate Nil Nil A summary of the changes in the Company’s stock options during the three months ended January 31, 2022 are as follows: SCHEDULE OF STOCK OPTIONS ACTIVITY Expiry Date Exercise Price Weighted Average Life (Years) Outstanding as at October 31, 2021 Granted Exercised Expired/ Cancelled Outstanding as at January 31, 2022 Vested as at January 31, 2022 March 27, 2022 0.05 0.15 1,500,000 – – (250,000 ) 1,250,000 1,250,000 December 30, 2022 0.13 0.91 6,000,000 – – – 6,000,000 6,000,000 August 12, 2023 0.05 1.53 2,290,000 – – (750,000 ) 1,540,000 1,540,000 December 3, 2023 0.05 1.84 6,450,000 – – (500,000 ) 5,950,000 5,950,000 May 22, 2024 0.12 2.31 7,900,000 – – (500,000 ) 7,400,000 7,400,000 November 3, 2024 0.15 2.76 700,000 – – – 700,000 700,000 November 24, 2024 0.16 2.82 320,000 – – – 320,000 320,000 March 26, 2025 0.11 3.15 100,000 – – – 100,000 100,000 April 23, 2025 0.12 3.23 3,350,000 – – – 3,350,000 3,350,000 December 30, 2025 0.13 3.92 9,500,000 – – – 9,500,000 9,500,000 August 30, 2026 0.70 4.58 21,700,000 – – – 21,700,000 21,475,000 October 1, 2026 0.50 4.67 1,450,000 – – – 1,450,000 1,450,000 December 3, 2026 0.58 4.84 – 250,000 – – 250,000 250,000 Total 61,260,000 250,000 – (2,000,000 ) 59,510,000 59,285,000 Weighted average exercise price CA$ 0.33 CA$ 0.58 – CA$ 0.07 CA$ 0.34 CA$ 0.33 Aggregate intrinsic value $ 19,994,025 $ 4,886,548 $ 4,93,542 Weighted average remaining life 3.46 3.27 3.26 A summary of the changes in the Company’s nonvested stock options during the year ended January 31, 2022 are as follows: SCHEDULE OF NONVESTED STOCK OPTIONS Expiry Date Fair Value Per Share Weighted Average Life (Years) Nonvested as at October 31, 2021 Granted Vested Expired/ Cancelled Nonvested as at January 31, 2022 December 30, 2022 0.07 1.16 162,500 – (162,500 ) – – August 30, 2026 0.56 4.83 300,000 – (75,000 ) – 225,000 Total 462,500 – (237,500 ) – 225,000 Weighted average grant date fair value – per option CA$ 0.39 – CA$ 0.22 – CA$ 0.56 Weighted average grant date fair value – total $ 144,131 – $ 41,571 – $ 98,764 A summary of the changes in the Company’s stock options during the three months ended January 31, 2021 are as follows: Expiry Date Exercise Price Weighted Average Life (Years) Outstanding as at October 31, 2020 Granted Exercised Expired/ Cancelled Outstanding as at January 31, 2021 Vested as at January 31, 2021 February 11, 2021 0.05 0.03 800,000 – – – 800,000 800,000 August 16, 2021 0.05 0.54 600,000 – – – 600,000 600,000 March 27, 2022 0.05 1.15 1,750,000 – – – 1,750,000 1,750,000 August 26, 2022 0.13 – 500,000 – – (500,000 ) – – December 30, 2022 0.13 1.91 – 6,150,000 – – 6,150,000 5,500,000 April 19, 2023 0.05 2.21 800,000 – – – 800,000 800,000 August 12, 2023 0.05 2.53 3,120,000 – – – 3,120,000 3,120,000 December 3, 2023 0.05 2.84 7,000,000 – – – 7,000,000 7,000,000 May 22, 2024 0.12 3.31 7,950,000 – – – 7,950,000 7,950,000 November 3, 2024 0.15 3.76 700,000 – – – 700,000 700,000 November 24, 2024 0.16 3.82 900,000 – – – 900,000 900,000 March 26, 2025 0.11 4.15 300,000 – – – 300,000 300,000 April 23, 2025 0.12 4.23 4,000,000 – – (300,000 ) 3,700,000 3,512,500 December 30, 2025 0.13 4.92 – 9,500,000 – – 9,500,000 9,500,000 Total 28,420,000 15,650,000 – (800,000 ) 43,270,000 42,432,500 Weighted average exercise price CA$ 0.09 CA$ 0.13 – CA$ 0.13 CA$ 0.10 CA$ 0.10 Aggregate intrinsic value $ 801,922 $ 743,918 $ 801,892 Weighted average remaining life 3.18 3.23 3.24 The intrinsic value of options exercised during the three months ended January 31, 2022 was $ nil nil [e] Share-based payments and other reserves The share-based payments and other reserves are used to recognize the fair value of stock options granted to directors, officers, employees and consultants as part of their remuneration, as well as those of broker warrants issued in relation to the Company’s financings. When stock options and broker warrants are subsequently exercised, the fair value of such stock options and broker warrants in additional paid-in capital is credited to share capital. Common share purchase warrants attached to units as part of a unit placement were assigned a $nil value. The residual method is used to calculate the fair value of the warrant component of units issued, whereby the residual of the private placement proceeds less the fair value of the share component is assigned as the fair value of the warrants. On November 1, 2021, the Company’s functional currency change resulted in the reclassification of its outstanding warrants and broker warrants denominated in the Canadian dollars as derivative liabilities. The previous value of outstanding broker warrants was reversed out of additional paid-in capital. On November 1, 2021, the Company’s functional currency change resulted in the reclassification of the June 2021 Convertible Debenture from a hybrid financial instrument to a convertible debt instrument with a beneficial conversion feature. The value of the embedded derivative liability was reclassified to additional paid-in capital. [f] Obligations to issue shares As at January 31, 2022, the Company received advance share subscriptions in the amount of $ 46,741 209,827 [g] Dilutive common shares As at January 31, 2022, potentially dilutive common shares relating to common share purchase warrants and options outstanding totaling 105,616,670 120,808,982

CAPITAL MANAGEMENT

CAPITAL MANAGEMENT	3 Months Ended
	Jan. 31, 2022
Capital Management
CAPITAL MANAGEMENT	14. CAPITAL MANAGEMENT The Company classifies the components of shareholders’ equity as capital, which at January 31, 2022, was a deficiency of $ 7,422,277 6,770,038

FINANCIAL INSTRUMENTS AND FINAN

FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT	3 Months Ended
	Jan. 31, 2022
Fair Value Disclosures [Abstract]
FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT	15. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT The Company’s classification of its financial instruments is as follows: SCHEDULE OF CLASSIFICATION OF ITS FINANCIAL INSTRUMENTS Financial Instruments Measurement Method Associated Risk Fair Value at January 31, 2022 ($) Cash FVTPL Credit and currency 772,522 Amounts receivable Amortized cost Credit and currency 235,821 Deposits held by related parties Amortized cost Credit and currency 565,741 Accounts payable and accrued liabilities Amortized cost Currency 2,552,509 Due to related parties Amortized cost Currency 1,092,786 Convertible debenture Amortized cost Currency 221,599 Derivative liability – warrants FVTPL Currency 8,288,387 [a] Fair value The fair value of financial instruments is the amount of consideration that would be agreed upon in an arm’s length transaction between knowledgeable, willing parties who are under no compulsion to act. The fair value of current financial instruments except derivative liability approximates their carrying values as long as they are short-term in nature or bear interest at market rates. [b] Fair value hierarchy Financial instruments that are held at fair value are categorized based on a valuation hierarchy which is determined by the valuation methodology utilized. The fair value hierarchy under US GAAP is based on the following three levels of inputs, of which the first two are considered observable and the last unobservable: Level 1 Level 2 Level 3 Cash and cash equivalents are valued using a market approach based upon unadjusted quoted prices for identical assets in an active market obtained from securities exchanges. As at January 31, 2022, the fair value of cash and cash equivalents held by the Company was based on Level 1 of the fair value hierarchy. There were no transfers between Levels 1 and 2 during the period. The Company evaluates its financial instruments and other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with ASC 815. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market at each balance sheet date and recorded as a liability and the change in fair value is recorded in the consolidated statements of loss and comprehensive loss. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Derivative instruments that become subject to reclassification are reclassified at the fair value of the instrument on the reclassification date. Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether or not settlement of the derivative instrument is expected within 12 months of the balance sheet date. The Company uses the Black-Scholes Option Pricing Model to value derivative liabilities. This model uses Level 3 inputs in the fair value hierarchy established by ASC 820 Fair Value Measurement. The inputs used in determining the fair value of the embedded derivative are disclosed in note 12[d] [c] Financial risk management The Company’s board of directors has the overall responsibility for the establishment and oversight of the Company’s risk management framework. The Company’s risk management policies are established to identify and analyze the risks faced by the Company, to set appropriate risk limits and controls, and to monitor risks and adherence to limits. Risk management policies and systems are reviewed regularly to reflect changes in market conditions and in response to the Company’s activities. Management regularly monitors compliance with the Company’s risk management policies and procedures and reviews the adequacy of the risk management framework in relation to the risks faced by the Company. In the normal course of operations, the Company is exposed to various risks such interest rate, foreign exchange, commodity, credit, and liquidity. To manage these risks, management determines what activities must be undertaken to minimize potential exposure to risks. The objectives of the Company in managing risks are as follows: ● Maintaining sound financial condition: ● Financing operations; and ● Ensuring liquidity to all operations. In order to satisfy these objectives, the Company has adopted the following policies: ● Prepare budget documents at prevailing market rates to ensure clear corporate alignment to performance management and achievement of targets; ● Recognize and observe the extent of operating risk within the business; and ● Identify the magnitude of the impact of market risk factors on the overall risk of the business and take advantage of natural risk reductions that arise from these relationships. [i] Interest rate risk Interest rate risk is the risk that future cash flows of a financial instrument will fluctuate because of changes in the market interest rates. The Company is exposed to interest rate risk on its cash on deposits with banks and, from time to time, on its holdings of short-term investments. As of January 31, 2022, the Company had $ 772,522 462,360 no [ii] Foreign currency risk The Company is exposed to foreign currency risk on fluctuations related to cash, amounts receivable, accounts payable, due to related parties and convertible debenture that are denominated in Canadian dollars. The Company has not entered into foreign exchange derivative contracts. A significant change in the currency exchange rates between the US dollar relative to the Canadian dollar could have a material effect on the Company’s financial position, results of operations, or cash flows. Based on the Company net exposures as at January 31, 2022, assuming that all other variables remain constant, a 5 88,138 SCHEDULE OF FOREIGN CURRENCY RISK January 31, 2022 CA$ Cash 498,538 Amounts receivable 299,940 Accounts payable and accrued liabilities (2,210,900 ) Due to related parties (729,621 ) Convertible debenture (100,000 ) Total (2,242,043 ) [iii] Commodity price risk The value of the Company’s magnesium production business and its exploration and evaluation assets are dependent on the price of magnesium and the outlook for this mineral. Market prices for these metals historically have fluctuated widely and are affected by numerous factors outside the Company’s control, including but not limited to, levels of worldwide production, short-term changes in supply and demand, industrial and retail demand, as well as certain other factors related specifically to magnesium. If magnesium prices decline for a prolonged period below the cost of production, it may not be economically feasible to continue towards production. [iv] Credit risk Credit risk is the risk of loss if counterparties do not fulfill their contractual obligations and arises principally from trade receivables. The Company’s credit risk is primarily attributable to cash, and deposits held by related parties. The Company limits its exposure to credit risk on cash as these financial instruments are held with major Canadian and international banks. Amounts receivable consist primarily of GST due from the Federal Government of Canada. Management believes the credit risk concentration with respect to amounts receivable is remote. The carrying amount of financial assets recorded in the financial statements, net of any allowances, represents the Company’s maximum exposure to credit risk. [v] Liquidity risk Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they come due. The Company’s exposure to liquidity risk is dependent on its purchasing commitments and obligations and its ability to raise funds to meet commitments and sustain operations. The Company manages liquidity risk by continuously monitoring its actual and forecasted working capital requirements to ensure there is capital to meet short-term and long-term obligations. As of January 31, 2022 and October 31, 2021, the Company had working capital deficiency of $ 10,900,774 9,657,316 note 1

SEGMENTED INFORMATION

SEGMENTED INFORMATION	3 Months Ended
	Jan. 31, 2022
Segment Reporting [Abstract]
SEGMENTED INFORMATION	16. SEGMENTED INFORMATION The Company focuses on plant operations and magnesium production and continues to move towards the buildout of its pilot plant facility and the development of a full-scale commercial magnesium production facility. The Company also owns mining claims for the exploration and development of mineral property interests. Geographic information for the Company’s assets is as follows: SCHEDULE OF ASSETS INFORMATION January 31, 2022 October 31, 2021 $ $ Canada – property, plant and equipment 3,128,142 2,546,383 United States – property, plant and equipment 31,101 28,321 United States – mineral property costs 93,453 93,453 3,252,696 2,668,157 Canada – other assets 838,067 1,554,827 United States – other assets 1,409,734 290,528 2,247,801 1,845,355 Total Assets 5,500,498 4,513,512

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Jan. 31, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	17. SUBSEQUENT EVENTS On March 10, 2022, the Company issued 1,000,000 1,000,000 500,000 0.13 500,000 0.19 Subsequent to January 31, 2022, upon exercise of common share purchase warrants, the Company issued an aggregate 1,793,657 0.19 340,795 1,082,025 0.05 54,101 1,305,200 Subsequent to January 31, 2022, the Company announced the appointment of a new Chief Financial Officer of the Company and the grant of 500,000 0.40 five years

PROPERTY, PLANT AND EQUIPMENT (

PROPERTY, PLANT AND EQUIPMENT (Tables)	3 Months Ended
	Jan. 31, 2022
Property, Plant and Equipment [Abstract]
SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT	SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT Computer Equipment Furniture Leasehold Improvement Furnace & Plant Equipment Vehicle Total $ $ $ $ $ $ Cost Balance, October 31, 2020 32,318 38,916 7,610 28,413 – 107,257 Additions 77,955 11,510 129,257 2,278,205 – 2,496,927 Write-off of equipment (4,245 ) – – – – (4,245 ) Foreign exchange effect 3,601 3,116 2,614 38,108 – 47,439 Balance, October 31, 2021 109,629 53,542 139,481 2,344,726 – 2,647,378 Cost, Beginning Balance 109,629 53,542 139,481 2,344,726 – 2,647,378 Additions – 2,171 21,932 634,067 29,215 687,385 Foreign exchange effect – (230 ) (3,611 ) (49,144 ) (136 ) (53,121 ) Balance, January 31, 2022 109,629 53,483 157,802 2,929,649 29,079 3,281,642 Cost, Ending Balance 109,629 53,483 157,802 2,929,649 29,079 3,281,642 Accumulated Depreciation Balance, October 31, 2020 14,677 8,326 4,818 – – 27,821 Depreciation expense 13,907 7,443 8,827 13,971 – 44,148 Write-off of equipment (2,057 ) – – – – (2,057 ) Foreign exchange effect 1,294 745 502 221 – 2,762 Balance, October 31, 2021 27,821 16,514 14,147 14,192 – 72,674 Accumulated Depreciation, Beginning Balance 27,821 16,514 14,147 14,192 – 72,674 Depreciation expense 8,794 1,880 4,656 34,374 730 50,434 Foreign exchange effect – (35 ) (230 ) (442 ) (3 ) (710 ) Balance, January 31, 2022 36,615 18,359 18,573 48,124 727 122,398 Accumulated Depreciation, Ending Balance 36,615 18,359 18,573 48,124 727 122,398 Net Book Value Balance, October 31, 2020 17,641 30,590 2,792 28,413 – 79,436 Balance, October 31, 2021 81,808 37,028 125,334 2,330,534 – 2,574,704 Balance, January 31, 2022 73,014 37,124 139,229 2,881,525 28,352 3,159,244

RIGHT-OF-USE ASSETS (Tables)

RIGHT-OF-USE ASSETS (Tables)	3 Months Ended
	Jan. 31, 2022
Right-of-use Assets
SCHEDULE OF RIGHT-OF-USE ASSETS	SCHEDULE OF RIGHT-OF-USE ASSETS Vancouver Office Virginia Office Nevada Office Pilot Plant Total $ $ $ $ $ Cost Balance, October 31, 2020 59,701 – 22,856 357,949 440,506 Additions 91,237 287,847 – – 379,084 Foreign exchange effect 5,943 4,544 1,724 26,997 39,208 Balance, October 31, 2021 156,881 292,391 24,580 384,946 858,798 Cost, beginning balance 156,881 292,391 24,580 384,946 858,798 Foreign exchange effect – – – (10,139 ) (10,139 ) Balance, January 31, 2022 156,881 292,391 24,580 374,807 848,659 Cost, ending balance 156,881 292,391 24,580 374,807 848,659 Accumulated Depreciation Balance, October 31, 2020 42,142 – 14,434 9,943 66,519 Depreciation expense 44,259 15,288 8,915 117,292 185,754 Foreign exchange effect 3,876 241 1,231 2,602 7,950 Balance, October 31, 2021 90,277 15,529 24,580 129,837 260,223 Accumulated depreciation, beginning balance 90,277 15,529 24,580 129,837 260,223 Depreciation expense 11,021 16,935 – 30,950 58,906 Foreign exchange effect – – – (3,563 ) (3,563 ) Balance, January 31, 2022 101,298 32,464 24,580 157,224 315,566 Accumulated depreciation, ending balance 101,298 32,464 24,580 157,224 315,566 Net Book Value Balance, October 31, 2020 17,559 – 8,422 348,006 373,987 Balance, October 31, 2021 66,604 276,862 – 255,109 598,575 Balance, January 31, 2022 55,583 259,927 – 217,583 533,093

LEASE OBLIGATIONS (Tables)

LEASE OBLIGATIONS (Tables)	3 Months Ended
	Jan. 31, 2022
Lease Obligations
SCHEDULE OF OPERATING LEASE	SCHEDULE OF OPERATING LEASE Vancouver Office Virginia Office Nevada Office Pilot Plant Total $ $ $ $ $ Balance, October 31, 2020 18,123 – 12,211 350,593 380,927 Additions 91,237 260,649 – – 351,886 Lease payments (47,931 ) (5,137 ) (9,457 ) (139,037 ) (201,562 ) Interest expenses 3,076 3,019 219 19,005 25,319 Prior period adjustment – – (3,065 ) – (3,065 ) Foreign exchange effect 2,099 4,081 92 24,548 30,820 Balance, October 31, 2021 66,604 262,612 – 255,109 584,325 Operating lease liability, beginning balance 66,604 262,612 – 255,109 584,325 Lease payments (12,097 ) – – (34,538 ) (46,635 ) Interest expenses 1,076 4,575 – 3,589 9,240 Foreign exchange effect – – – (6,576 ) (6,576 ) Balance, January 31, 2022 55,583 267,187 – 217,584 540,354 Operating lease liability, ending balance 55,583 267,187 – 217,584 540,354 Which consist of: Current lease obligation 47,548 44,823 – 127,938 220,309 Non-current lease obligation 8,035 222,364 – 89,646 320,045 Balance, January 31, 2022 55,583 267,187 – 217,584 540,354 Operating lease liability, ending balance 55,583 267,187 – 217,584 540,354

RELATED PARTY TRANSACTIONS (Tab

RELATED PARTY TRANSACTIONS (Tables)	3 Months Ended
	Jan. 31, 2022
Related Party Transactions [Abstract]
SCHEDULE OF DEPOSITS HELD BY RELATED PARTY	SCHEDULE OF DEPOSITS HELD BY RELATED PARTY Related Party A [i] Related Party B [ii] Total $ $ $ Balance, October 31, 2020 – – – Advances 987,912 2,292,912 3,280,824 Costs and expenses (696,431 ) (2,097,931 ) (2,794,362 ) Balance, October 31, 2021 291,481 194,981 486,462 Advances 300,000 522,335 822,335 Costs and expenses (79,793 ) (675,390 ) (755,183 ) Foreign exchange effect 13,193 (1,066 ) 12,127 Balance, January 31, 2022 524,881 40,860 565,741 [i] Related Party A is a company controlled by a director and officer. [ii] Related Party B is a company controlled by an officer.
SCHEDULE OF DUE TO RELATED PARTIES	SCHEDULE OF DUE TO RELATED PARTIES January 31, 2022 October 31, 2021 $ $ Wages payable to directors and officers 357,500 357,500 Benefits payable to directors and officers 581,854 539,209 Fees and expenses payable to directors and officers 151,261 127,878 Interests due to a shareholder 2,171 2,230 Total 1,092,786 1,026,817

CONVERTIBLE DEBENTURE AND DER_2

CONVERTIBLE DEBENTURE AND DERIVATIVE LIABILITY (Tables)	3 Months Ended
	Jan. 31, 2022
Debt Disclosure [Abstract]
SCHEDULE OF OPTION PRICING MODEL	The inputs used in the Black-Scholes Option Pricing Model are as follows: SCHEDULE OF OPTION PRICING MODEL January 31, November 1, October 31, June 15, July 27, 2022 2021 2021 2021 2020 Risk free rate of interest 1.51 % 1.07 % 1.08 % 0.31 % 0.26 % Expected life in years 0.45 0.70 1.11 1.50 0.74 Conversion exercise price CA$ 0.12 CA$ 0.12 $ 0.10 $ 0.10 CA$ 0.15 Underlying share price of the Company CA$ 0.44 CA$ 0.75 $ 0.59 $ 0.19 CA$ 0.13 Expected volatility 109.11 % 124.34 % 107.62 % 87.17 % 82.54 % Expected dividend rate Nil Nil Nil Nil Nil
SCHEDULE OF DERIVATIVE INSTRUMENTS	SCHEDULE OF DERIVATIVE INSTRUMENTS July 2020 Convertible Debenture June 2021 Convertible Debenture July 2021 Convertible Debenture Total $ $ $ $ Debt Host Liability Balance, October 31, 2020 96,318 – – 96,318 Value of debt host liability recognized – 1 – 1 Accretion and interest expense 23,587 43 63 23,693 Conversion (125,560 ) – – (125,560 ) Foreign currency translation 5,655 – – 5,655 Balance, October 31, 2021 – 44 63 107 Effects of change in functional currency – 1,500,000 – 1,500,000 Accretion and interest expense – 529 9,244 9,773 Conversion – (300,000 ) – (300,000 ) Foreign currency translation – – (45 ) (45 ) Balance, January 31, 2022 – 1,200,573 9,262 1,209,835 Embedded Derivative Liability Balance, October 31, 2020 20,123 – – 20,123 Fair value of embedded derivative liability recognized – 1,646,600 – 1,646,600 Fair value adjustment (16,058 ) 5,717,328 – 5,701,270 Conversion (5,247 ) – – (5,247 ) Foreign currency translation 1,182 85,772 – 86,954 Balance, October 31, 2021 – 7,449,700 – 7,449,700 Effects of change in functional currency – (7,449,700 ) 421,094 (7,028,606 ) Fair value adjustment – – (205,450 ) (205,450 ) Foreign currency translation – – (3,914 ) (3,914 ) Balance, January 31, 2022 – – 211,730 211,730 Debt Discount Balance, October 31, 2021 – – – – Effects of change in functional currency – (1,500,000 ) – (1,500,000 ) Amortization – 300,034 – 300,034 Balance, January 31, 2022 – (1,199,966 ) – (1,199,966 ) Combined Value of Convertible Debenture Balance, October 31, 2020 116,441 – – 116,441 Balance, October 31, 2021 – 7,449,744 63 7,449,807 Balance, January 31, 2022 – 607 220,992 221,599

SHARE CAPITAL (Tables)

SHARE CAPITAL (Tables)	3 Months Ended
	Jan. 31, 2022
Equity [Abstract]
SUMMARY OF CHANGES IN COMMON SHARE PURCHASE WARRANTS	A summary of the changes in the Company’s common share purchase warrants during the three months ended January 31, 2022 are as follows: SUMMARY OF CHANGES IN COMMON SHARE PURCHASE WARRANTS Expiry Date Exercise Price Weighted Average Life (Years) October 31, 2021 Granted Exercised Expired/ Cancelled January 31, 2022 Expiry Date Exercise Price Weighted Average Life (Years) October 31, 2021 Granted Exercised Expired/ Cancelled January 31, 2022 November 22, 2021 CA$ 0.19 – 4,160,021 – (4,080,573 ) (79,448 ) – January 17, 2022 CA$ 0.19 – 7,267,914 – (5,959,396 ) (1,308,518 ) – January 31, 2022 CA$ 0.19 – 5,382,303 – (4,341,906 ) (1,040,397 ) – February 21, 2022 CA$ 0.05 0.06 1,505,200 – – – 1,505,200 March 24, 2022 CA$ 0.19 0.14 6,341,872 – (570,046 ) – 5,771,826 March 27, 2022 CA$ 0.05 0.15 982,025 – – – 982,025 April 27, 2022 CA$ 0.19 0.24 791,395 – (50,000 ) – 741,395 May 9, 2022 CA$ 0.05 0.27 1,813,725 – – – 1,813,725 May 30, 2022 CA$ 0.19 0.33 5,223,420 – (47,527 ) – 5,175,893 June 17, 2022 CA$ 0.19 0.38 17,703,506 – (110,000 ) – 17,593,506 July 18, 2022 CA$ 0.30 0.46 4,350,000 – (30,000 ) – 4,320,000 August 14, 2022 CA$ 0.05 0.53 200,000 – (200,000 ) – – February 13, 2023 CA$ 0.65 1.04 3,827,601 – – – 3,827,601 Subtotal 59,548,982 – (15,389,448 ) (2,428,363 ) 41,731,171 Weighted average exercise price CA$ 0.22 – CA$ 0.19 CA$ 0.19 CA$ 0.23 November 27, 2022 US$ 0.75 0.82 – 1,375,499 – – 1,375,499 June 10, 2026 US$ 0.13 4.36 – 1,500,000 – – 1,500,000 June 10, 2026 US$ 0.19 4.36 – 1,500,000 – – 1,500,000 Subtotal – 4,375,499 – – 4,375,499 Weighted average exercise price – US$ 0.35 – – US$ 0.35 Total 59,548,982 4,375,499 (15,389,448 ) (2,428,363 ) 46,106,670 A summary of the changes in the Company’s common share purchase warrants during the three months ended January 31, 2021 are as follows: Expiry Date Exercise Price ($) Weighted Average Life (Years) October 31, 2020 Granted Exercised Expired/ Cancelled January 31, 2021 Expiry Date Exercise Price Weighted Average Life (Years) October 31, 2020 Granted Exercised Expired/ Cancelled January 31, 2021 August 31, 2021 * CA$ 0.21 0.58 3,643,791 - – – 3,643,791 November 22, 2021 CA$0.19 0.80 – 5,599,171 – – 5,599,171 January 17, 2022 CA$0.19 0.96 – 7,337,914 – – 7,337,914 January 31, 2022 CA$0.19 0.99 – 5,382,303 – – 5,382,303 February 21, 2022 CA$0.05 1.06 1,505,200 – – – 1,505,200 March 27, 2022 CA$0.05 1.15 1,482,025 – – – 1,482,025 May 9, 2022 CA$0.05 1.27 2,368,626 – – – 2,368,626 August 14, 2022 CA$0.05 1.53 1,110,000 – – – 1,110,000 Total 10,109,642 18,319,388 – – 28,429,030 Weighted average exercise price CA$ 0.11 CA$ 0.19 – – CA$ 0.16 * The Company received approval of the TSX-V on January 13, 2021 and amended the expiry date of 3,643,791 extending the expiry date from January 17, 2021 to August 31, 2021 0.30 10
SCHEDULE OF ASSUMPTIONS USED	SCHEDULE OF ASSUMPTIONS USED 2022 2021 Risk free rate of interest 1.34 % 0.20 1.07 Expected life of options 5 2 5 Exercise price of options CA$ 0.58 CA$ 0.13 0.70 Expected annualized volatility 136.08 % 130.88 140.05 Expected dividend rate Nil Nil
SCHEDULE OF STOCK OPTIONS ACTIVITY	A summary of the changes in the Company’s stock options during the three months ended January 31, 2022 are as follows: SCHEDULE OF STOCK OPTIONS ACTIVITY Expiry Date Exercise Price Weighted Average Life (Years) Outstanding as at October 31, 2021 Granted Exercised Expired/ Cancelled Outstanding as at January 31, 2022 Vested as at January 31, 2022 March 27, 2022 0.05 0.15 1,500,000 – – (250,000 ) 1,250,000 1,250,000 December 30, 2022 0.13 0.91 6,000,000 – – – 6,000,000 6,000,000 August 12, 2023 0.05 1.53 2,290,000 – – (750,000 ) 1,540,000 1,540,000 December 3, 2023 0.05 1.84 6,450,000 – – (500,000 ) 5,950,000 5,950,000 May 22, 2024 0.12 2.31 7,900,000 – – (500,000 ) 7,400,000 7,400,000 November 3, 2024 0.15 2.76 700,000 – – – 700,000 700,000 November 24, 2024 0.16 2.82 320,000 – – – 320,000 320,000 March 26, 2025 0.11 3.15 100,000 – – – 100,000 100,000 April 23, 2025 0.12 3.23 3,350,000 – – – 3,350,000 3,350,000 December 30, 2025 0.13 3.92 9,500,000 – – – 9,500,000 9,500,000 August 30, 2026 0.70 4.58 21,700,000 – – – 21,700,000 21,475,000 October 1, 2026 0.50 4.67 1,450,000 – – – 1,450,000 1,450,000 December 3, 2026 0.58 4.84 – 250,000 – – 250,000 250,000 Total 61,260,000 250,000 – (2,000,000 ) 59,510,000 59,285,000 Weighted average exercise price CA$ 0.33 CA$ 0.58 – CA$ 0.07 CA$ 0.34 CA$ 0.33 Aggregate intrinsic value $ 19,994,025 $ 4,886,548 $ 4,93,542 Weighted average remaining life 3.46 3.27 3.26 Expiry Date Exercise Price Weighted Average Life (Years) Outstanding as at October 31, 2020 Granted Exercised Expired/ Cancelled Outstanding as at January 31, 2021 Vested as at January 31, 2021 February 11, 2021 0.05 0.03 800,000 – – – 800,000 800,000 August 16, 2021 0.05 0.54 600,000 – – – 600,000 600,000 March 27, 2022 0.05 1.15 1,750,000 – – – 1,750,000 1,750,000 August 26, 2022 0.13 – 500,000 – – (500,000 ) – – December 30, 2022 0.13 1.91 – 6,150,000 – – 6,150,000 5,500,000 April 19, 2023 0.05 2.21 800,000 – – – 800,000 800,000 August 12, 2023 0.05 2.53 3,120,000 – – – 3,120,000 3,120,000 December 3, 2023 0.05 2.84 7,000,000 – – – 7,000,000 7,000,000 May 22, 2024 0.12 3.31 7,950,000 – – – 7,950,000 7,950,000 November 3, 2024 0.15 3.76 700,000 – – – 700,000 700,000 November 24, 2024 0.16 3.82 900,000 – – – 900,000 900,000 March 26, 2025 0.11 4.15 300,000 – – – 300,000 300,000 April 23, 2025 0.12 4.23 4,000,000 – – (300,000 ) 3,700,000 3,512,500 December 30, 2025 0.13 4.92 – 9,500,000 – – 9,500,000 9,500,000 Total 28,420,000 15,650,000 – (800,000 ) 43,270,000 42,432,500 Weighted average exercise price CA$ 0.09 CA$ 0.13 – CA$ 0.13 CA$ 0.10 CA$ 0.10 Aggregate intrinsic value $ 801,922 $ 743,918 $ 801,892 Weighted average remaining life 3.18 3.23 3.24
SCHEDULE OF NONVESTED STOCK OPTIONS	A summary of the changes in the Company’s nonvested stock options during the year ended January 31, 2022 are as follows: SCHEDULE OF NONVESTED STOCK OPTIONS Expiry Date Fair Value Per Share Weighted Average Life (Years) Nonvested as at October 31, 2021 Granted Vested Expired/ Cancelled Nonvested as at January 31, 2022 December 30, 2022 0.07 1.16 162,500 – (162,500 ) – – August 30, 2026 0.56 4.83 300,000 – (75,000 ) – 225,000 Total 462,500 – (237,500 ) – 225,000 Weighted average grant date fair value – per option CA$ 0.39 – CA$ 0.22 – CA$ 0.56 Weighted average grant date fair value – total $ 144,131 – $ 41,571 – $ 98,764

FINANCIAL INSTRUMENTS AND FIN_2

FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (Tables)	3 Months Ended
	Jan. 31, 2022
Fair Value Disclosures [Abstract]
SCHEDULE OF CLASSIFICATION OF ITS FINANCIAL INSTRUMENTS	The Company’s classification of its financial instruments is as follows: SCHEDULE OF CLASSIFICATION OF ITS FINANCIAL INSTRUMENTS Financial Instruments Measurement Method Associated Risk Fair Value at January 31, 2022 ($) Cash FVTPL Credit and currency 772,522 Amounts receivable Amortized cost Credit and currency 235,821 Deposits held by related parties Amortized cost Credit and currency 565,741 Accounts payable and accrued liabilities Amortized cost Currency 2,552,509 Due to related parties Amortized cost Currency 1,092,786 Convertible debenture Amortized cost Currency 221,599 Derivative liability – warrants FVTPL Currency 8,288,387
SCHEDULE OF FOREIGN CURRENCY RISK	SCHEDULE OF FOREIGN CURRENCY RISK January 31, 2022 CA$ Cash 498,538 Amounts receivable 299,940 Accounts payable and accrued liabilities (2,210,900 ) Due to related parties (729,621 ) Convertible debenture (100,000 ) Total (2,242,043 )

SEGMENTED INFORMATION (Tables)

SEGMENTED INFORMATION (Tables)	3 Months Ended
	Jan. 31, 2022
Segment Reporting [Abstract]
SCHEDULE OF ASSETS INFORMATION	SCHEDULE OF ASSETS INFORMATION January 31, 2022 October 31, 2021 $ $ Canada – property, plant and equipment 3,128,142 2,546,383 United States – property, plant and equipment 31,101 28,321 United States – mineral property costs 93,453 93,453 3,252,696 2,668,157 Canada – other assets 838,067 1,554,827 United States – other assets 1,409,734 290,528 2,247,801 1,845,355 Total Assets 5,500,498 4,513,512

NATURE OF OPERATIONS AND GOIN_2

NATURE OF OPERATIONS AND GOING CONCERN (Details Narrative) - USD ($)	3 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Oct. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Retained Earnings (Accumulated Deficit)	$ 67,076,150		$ 52,129,621
Working capital deficit	10,900,774		$ 9,657,316
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest	$ 14,781,749	$ 2,210,772

SCHEDULE OF PROPERTY, PLANT AND

SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) - USD ($)	3 Months Ended		12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Oct. 31, 2021	Oct. 31, 2020
Property, Plant and Equipment [Line Items]
Cost, Beginning Balance	$ 2,647,378	$ 107,257	$ 107,257
Additions	687,385		2,496,927
Write-off of equipment			(4,245)
Foreign exchange effect	(53,121)		47,439
Cost, Ending Balance	3,281,642		2,647,378
Accumulated Depreciation, Beginning Balance	72,674	27,821	27,821
Depreciation expense	50,434	4,039	44,148
Write-off of equipment			(2,057)
Foreign exchange effect	(710)		2,762
Accumulated Depreciation, Ending Balance	122,398		72,674
Net Book Value	3,159,244		2,574,704	$ 79,436
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Cost, Beginning Balance	109,629	32,318	32,318
Additions			77,955
Write-off of equipment			(4,245)
Foreign exchange effect			3,601
Cost, Ending Balance	109,629		109,629
Accumulated Depreciation, Beginning Balance	27,821	14,677	14,677
Depreciation expense	8,794		13,907
Write-off of equipment			(2,057)
Foreign exchange effect			1,294
Accumulated Depreciation, Ending Balance	36,615		27,821
Net Book Value	73,014		81,808	17,641
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Cost, Beginning Balance	53,542	38,916	38,916
Additions	2,171		11,510
Write-off of equipment
Foreign exchange effect	(230)		3,116
Cost, Ending Balance	53,483		53,542
Accumulated Depreciation, Beginning Balance	16,514	8,326	8,326
Depreciation expense	1,880		7,443
Write-off of equipment
Foreign exchange effect	(35)		745
Accumulated Depreciation, Ending Balance	18,359		16,514
Net Book Value	37,124		37,028	30,590
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Cost, Beginning Balance	139,481	7,610	7,610
Additions	21,932		129,257
Write-off of equipment
Foreign exchange effect	(3,611)		2,614
Cost, Ending Balance	157,802		139,481
Accumulated Depreciation, Beginning Balance	14,147	4,818	4,818
Depreciation expense	4,656		8,827
Write-off of equipment
Foreign exchange effect	(230)		502
Accumulated Depreciation, Ending Balance	18,573		14,147
Net Book Value	139,229		125,334	2,792
Furnace and Plant Equipment [Member]
Property, Plant and Equipment [Line Items]
Cost, Beginning Balance	2,344,726	28,413	28,413
Additions	634,067		2,278,205
Write-off of equipment
Foreign exchange effect	(49,144)		38,108
Cost, Ending Balance	2,929,649		2,344,726
Accumulated Depreciation, Beginning Balance	14,192
Depreciation expense	34,374		13,971
Write-off of equipment
Foreign exchange effect	(442)		221
Accumulated Depreciation, Ending Balance	48,124		14,192
Net Book Value	2,881,525		2,330,534	28,413
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Cost, Beginning Balance
Additions	29,215
Write-off of equipment
Foreign exchange effect	(136)
Cost, Ending Balance	29,079
Accumulated Depreciation, Beginning Balance
Depreciation expense	730
Write-off of equipment
Foreign exchange effect	(3)
Accumulated Depreciation, Ending Balance	727
Net Book Value	$ 28,352

SCHEDULE OF RIGHT-OF-USE ASSETS

SCHEDULE OF RIGHT-OF-USE ASSETS (Details) - USD ($)	3 Months Ended		12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Oct. 31, 2021	Oct. 31, 2020
Cost, beginning balance	$ 858,798	$ 440,506	$ 440,506
Additions			379,084
Foreign exchange effect	(10,139)		39,208
Cost, ending balance	848,659		858,798
Accumulated depreciation, beginning balance	260,223	66,519	66,519
Depreciation expense	58,906	47,287	185,754
Foreign exchange effect	(3,563)		7,950
Accumulated depreciation, ending balance	315,566		260,223
Net Book Value	533,093		598,575	$ 373,987
Vancouver Office [Member]
Cost, beginning balance	156,881	59,701	59,701
Additions			91,237
Foreign exchange effect			5,943
Cost, ending balance	156,881		156,881
Accumulated depreciation, beginning balance	90,277	42,142	42,142
Depreciation expense	11,021		44,259
Foreign exchange effect			3,876
Accumulated depreciation, ending balance	101,298		90,277
Net Book Value	55,583		66,604	17,559
Virginia Office [Member]
Cost, beginning balance	292,391
Additions			287,847
Foreign exchange effect			4,544
Cost, ending balance	292,391		292,391
Accumulated depreciation, beginning balance	15,529
Depreciation expense	16,935		15,288
Foreign exchange effect			241
Accumulated depreciation, ending balance	32,464		15,529
Net Book Value	259,927		276,862
Nevada Office [Member]
Cost, beginning balance	24,580	22,856	22,856
Additions
Foreign exchange effect			1,724
Cost, ending balance	24,580		24,580
Accumulated depreciation, beginning balance	24,580	14,434	14,434
Depreciation expense			8,915
Foreign exchange effect			1,231
Accumulated depreciation, ending balance	24,580		24,580
Net Book Value				8,422
Pilot Plant [Member]
Cost, beginning balance	384,946	357,949	357,949
Additions
Foreign exchange effect	(10,139)		26,997
Cost, ending balance	374,807		384,946
Accumulated depreciation, beginning balance	129,837	$ 9,943	9,943
Depreciation expense	30,950		117,292
Foreign exchange effect	(3,563)		2,602
Accumulated depreciation, ending balance	157,224		129,837
Net Book Value	$ 217,583		$ 255,109	$ 348,006

SCHEDULE OF OPERATING LEASE (De

SCHEDULE OF OPERATING LEASE (Details) - USD ($)	3 Months Ended	12 Months Ended
	Jan. 31, 2022	Oct. 31, 2021
Operating lease liability, beginning balance	$ 584,325	$ 380,927
Additions		351,886
Lease payments	(46,635)	(201,562)
Interest expenses	9,240	25,319
Prior period adjustment		(3,065)
Foreign exchange effect	(6,576)	30,820
Operating lease liability, ending balance	540,354	584,325
Current lease obligation	220,309	192,045
Non-current lease obligation	320,045	392,280
Vancouver Office [Member]
Operating lease liability, beginning balance	66,604	18,123
Additions		91,237
Lease payments	(12,097)	(47,931)
Interest expenses	1,076	3,076
Prior period adjustment
Foreign exchange effect		2,099
Operating lease liability, ending balance	55,583	66,604
Current lease obligation	47,548
Non-current lease obligation	8,035
Virginia Office [Member]
Operating lease liability, beginning balance	262,612
Additions		260,649
Lease payments		(5,137)
Interest expenses	4,575	3,019
Prior period adjustment
Foreign exchange effect		4,081
Operating lease liability, ending balance	267,187	262,612
Current lease obligation	44,823
Non-current lease obligation	222,364
Nevada Office [Member]
Operating lease liability, beginning balance		12,211
Additions
Lease payments		(9,457)
Interest expenses		219
Prior period adjustment		(3,065)
Foreign exchange effect		92
Operating lease liability, ending balance
Current lease obligation
Non-current lease obligation
Pilot Plant [Member]
Operating lease liability, beginning balance	255,109	350,593
Additions
Lease payments	(34,538)	(139,037)
Interest expenses	3,589	19,005
Prior period adjustment
Foreign exchange effect	(6,576)	24,548
Operating lease liability, ending balance	217,584	$ 255,109
Current lease obligation	127,938
Non-current lease obligation	$ 89,646

LEASE OBLIGATIONS (Details Narr

LEASE OBLIGATIONS (Details Narrative) - USD ($)	Jan. 31, 2022	Oct. 31, 2021	Oct. 31, 2020	Nov. 02, 2019
Operating Lease, Liability	$ 540,354	$ 584,325	$ 380,927	$ 83,549
Lessee, Operating Lease, Discount Rate				7.00%
British Columbia [Member]
Operating Lease, Liability		$ 91,237	$ 354,263
Lessee, Operating Lease, Discount Rate		7.00%	6.00%
McLean,Virginia [Member]
Operating Lease, Liability		$ 260,649
Lessee, Operating Lease, Discount Rate		7.00%

MINERAL PROPERTY COSTS (Details

MINERAL PROPERTY COSTS (Details Narrative)	Jan. 31, 2022USD ($)aha	Oct. 31, 2021USD ($)
Reserve Quantities [Line Items]
Mineral properties, net	$ 93,453	$ 93,453
Silverado Property [Member]
Reserve Quantities [Line Items]
Area of land | ha	120
Ownership percentage	100.00%
Mineral properties, net	$ 1
Tami Mosi Property [Member]
Reserve Quantities [Line Items]
Mineral properties, net	$ 93,452
Tami Mosi Property [Member] | White Pine County [Member]
Reserve Quantities [Line Items]
Area of land | a	1,637
Ownership percentage	100.00%
Tami Mosi Property [Member] | Moor Mining District [Member]
Reserve Quantities [Line Items]
Area of land | a	10
Ownership percentage	2.00%

SCHEDULE OF DEPOSITS HELD BY RE

SCHEDULE OF DEPOSITS HELD BY RELATED PARTY (Details) - USD ($)		3 Months Ended	12 Months Ended
		Jan. 31, 2022	Oct. 31, 2021
Related Party Transaction [Line Items]
Balance, October 31, 2021		$ 486,462
Advances		822,335	3,280,824
Costs and expenses		(755,183)	(2,794,362)
Foreign exchange effect		12,127
Balance, January 31, 2022		565,741	486,462
Related Party A [Member]
Related Party Transaction [Line Items]
Balance, October 31, 2021	[1]	291,481
Advances	[1]	300,000	987,912
Costs and expenses	[1]	(79,793)	(696,431)
Foreign exchange effect	[1]	13,193
Balance, January 31, 2022	[1]	524,881	291,481
Related Party B [Member]
Related Party Transaction [Line Items]
Balance, October 31, 2021	[2]	194,981
Advances	[2]	522,335	2,292,912
Costs and expenses	[2]	(675,390)	(2,097,931)
Foreign exchange effect	[2]	(1,066)
Balance, January 31, 2022	[2]	$ 40,860	$ 194,981
[1]	Related Party A is a company controlled by a director and officer.
[2]	Related Party B is a company controlled by an officer.

SCHEDULE OF DUE TO RELATED PART

SCHEDULE OF DUE TO RELATED PARTIES (Details) - USD ($)	Jan. 31, 2022	Oct. 31, 2021
Related Party Transactions [Abstract]
Wages payable to directors and officers	$ 357,500	$ 357,500
Benefits payable to directors and officers	581,854	539,209
Fees and expenses payable to directors and officers	151,261	127,878
Interests due to a shareholder	2,171	2,230
Total	$ 1,092,786	$ 1,026,817

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative)	Nov. 03, 2021USD ($)$ / sharesshares	Sep. 12, 2018	Aug. 28, 2018USD ($)	Jun. 30, 2021USD ($)	Jun. 30, 2021CAD ($)	Jan. 31, 2022USD ($)shares	Jan. 31, 2022CAD ($)shares	Jan. 31, 2021USD ($)	Nov. 03, 2021CAD ($)	Oct. 31, 2021USD ($)
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Due to related parties						$ 1,092,786				$ 1,026,817
Share-based payment arrangement, expense						2,900,000
Salaries management and consulting fees						747,589
Consulting fees						23,587	$ 30,000
Payments for rent				$ 7,700	$ 9,794
Number of common stock issued						$ 546,697		$ 1,256,934
Number of common stock issued, shares | shares
Fair value of share issue	$ 4,796,832								$ 5,956,226
Related Party Agreement [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Number of common stock issued, shares | shares	9,163,425
Share price | $ / shares	$ 0.65
Director and Officer [Member] | Related Party Agreement [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Equity method investment, ownership percentage		5.00%
Number of common stock issued			$ 5,000,000

CONTINGENT LIABILITIES AND CO_2

CONTINGENT LIABILITIES AND COMMITMENTS (Details Narrative) $ / shares in Units, shares in Millions

Feb. 08, 2021USD ($)shares

Feb. 08, 2021CAD ($)shares

Dec. 31, 2020USD ($)

Dec. 31, 2020CAD ($)

Sep. 29, 2020USD ($)

Sep. 30, 2021USD ($)

Jun. 30, 2021USD ($)

Jun. 30, 2021CAD ($)

Jan. 31, 2022USD ($)shares

Jan. 31, 2022CAD ($)shares

Oct. 31, 2020USD ($)

Oct. 31, 2020CAD ($)

Nov. 03, 2021$ / shares

Oct. 31, 2021USD ($)

Apr. 19, 2021USD ($)

Nov. 01, 2016USD ($)

Nov. 01, 2016CAD ($)$ / shares

Loss Contingencies [Line Items]

Loss contingency, damages sought, value

$ 3,900,000

$ 4,900,000

$ 3,400,000

$ 4,200,000

Debt instrument, face amount

$ 53,491

$ 53,491

Commitment of cash or arrangments amount

$ 1,800

$ 2,500

Number of shares issued price per share | $ / shares

$ 0.65

$ 0.05

Cash

Number of shares issued | shares

Sublease income

$ 7,909

$ 9,794

$ 16,727

$ 20,715

Payments for tenant allowance

$ 41,010

Lampert Agreement [Member]

Loss Contingencies [Line Items]

Debt instrument, face amount

$ 367,227

Percentage of interest rate owned

9.00%

Lease Agreement [Member]

Loss Contingencies [Line Items]

Sublease income

$ 9,113

Maximum [Member]

Loss Contingencies [Line Items]

Loss contingency, damages sought, value

$ 2,500,000

Purchase of warrants | shares

33

33

Issuance of share based minimum requirement

$ 1,800

$ 2,500

PROMISSORY NOTE (Details Narrat

PROMISSORY NOTE (Details Narrative)	3 Months Ended		12 Months Ended
	Jan. 31, 2022USD ($)	Jan. 31, 2021USD ($)	Oct. 31, 2021USD ($)	Oct. 31, 2020USD ($)	Oct. 31, 2020CAD ($)	Oct. 31, 2019USD ($)	Oct. 31, 2019CAD ($)
Related party loan						$ 112,895	$ 150,000
Percentage of unsecured loan interest						18.00%	18.00%
Interest and debt expense			$ 1,639	$ 16,655
Repayments of debt		$ 27,202
Promissory Note [Member]
Repayments of debt			$ 65,761	101,066
Minimum [Member]
Additional increase in promissory note loan				44,588	$ 60,000
Maximum [Member]
Additional increase in promissory note loan				$ 157,483	$ 210,000

PROVISION FOR FLOW THROUGH SH_2

PROVISION FOR FLOW THROUGH SHARE ISSUANCES (Details Narrative) - USD ($)	Jan. 31, 2022	Oct. 31, 2021
Provision For Flow Through Share Issuances
Provision for tax and related obligations	$ 227,140	$ 233,285

SCHEDULE OF OPTION PRICING MODE

SCHEDULE OF OPTION PRICING MODEL (Details)	Jan. 31, 2022$ / shares	Nov. 02, 2021$ / shares	Oct. 31, 2021$ / shares	Jun. 15, 2021$ / shares	Jul. 27, 2020$ / shares	Oct. 31, 2021$ / shares	Jan. 31, 2022$ / shares	Oct. 31, 2021$ / shares
Debt Disclosure [Abstract]
Risk free rate of interest	1.51%	1.07%	1.08%	0.31%	0.26%		1.34%
Expected life in years	5 months 12 days	8 months 12 days		1 year 6 months	8 months 26 days	1 year 1 month 9 days	5 years
Conversion exercise price | (per share)	$ 0.12	$ 0.12	$ 0.10	$ 0.10	$ 0.15	$ 0.10	$ 0.12	$ 0.10
Underlying share price of the Company | (per share)	$ 0.44	$ 0.75	$ 0.59	$ 0.19	$ 0.13	$ 0.59	$ 0.44	$ 0.59
Expected volatility	109.11%	124.34%	107.62%	87.17%	82.54%		136.08%
Expected dividend rate

SCHEDULE OF DERIVATIVE INSTRUME

SCHEDULE OF DERIVATIVE INSTRUMENTS (Details) - USD ($)	3 Months Ended		12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Oct. 31, 2021
Short-term Debt [Line Items]
Balance, beginning	$ 7,449,807
Accretion and interest expense	322,280	$ 18,574
Foreign currency translation	164,780	(87,762)
Balance, ending	221,599		$ 7,449,807
Fair value adjustment	(11,559,791)	(14,534)
Amortization	300,034
Debt Host Liability [Member]
Short-term Debt [Line Items]
Balance, beginning	107	96,318	96,318
Value of debt host liability recognized			1
Accretion and interest expense	9,773		23,693
Conversion	(300,000)		(125,560)
Foreign currency translation	(45)		5,655
Effects of change in functional currency	1,500,000
Balance, ending	1,209,835		107
Debt Host Liability [Member] | July 2020 Convertible Debenture [Member]
Short-term Debt [Line Items]
Balance, beginning		96,318	96,318
Value of debt host liability recognized
Accretion and interest expense			23,587
Conversion			(125,560)
Foreign currency translation			5,655
Effects of change in functional currency
Balance, ending
Debt Host Liability [Member] | June 2021 Convertible Debenture [Member]
Short-term Debt [Line Items]
Balance, beginning	44
Value of debt host liability recognized			1
Accretion and interest expense	529		43
Conversion	(300,000)
Foreign currency translation
Effects of change in functional currency	1,500,000
Balance, ending	1,200,573		44
Debt Host Liability [Member] | July 2021 Convertible Debenture [Member]
Short-term Debt [Line Items]
Balance, beginning	63
Value of debt host liability recognized
Accretion and interest expense	9,244		63
Conversion
Foreign currency translation	(45)
Effects of change in functional currency
Balance, ending	9,262		63
Embedded Derivative Liability [Member]
Short-term Debt [Line Items]
Balance, beginning	7,449,700	20,123	20,123
Conversion			(5,247)
Foreign currency translation	(3,914)		86,954
Effects of change in functional currency	(7,028,606)
Balance, ending	211,730		7,449,700
Fair value of embedded derivative liability recognized			1,646,600
Fair value adjustment	(205,450)		5,701,270
Embedded Derivative Liability [Member] | July 2020 Convertible Debenture [Member]
Short-term Debt [Line Items]
Balance, beginning		20,123	20,123
Conversion			(5,247)
Foreign currency translation			1,182
Effects of change in functional currency
Balance, ending
Fair value of embedded derivative liability recognized
Fair value adjustment			(16,058)
Embedded Derivative Liability [Member] | June 2021 Convertible Debenture [Member]
Short-term Debt [Line Items]
Balance, beginning	7,449,700
Conversion
Foreign currency translation			85,772
Effects of change in functional currency	(7,449,700)
Balance, ending			7,449,700
Fair value of embedded derivative liability recognized			1,646,600
Fair value adjustment			5,717,328
Embedded Derivative Liability [Member] | July 2021 Convertible Debenture [Member]
Short-term Debt [Line Items]
Balance, beginning
Conversion
Foreign currency translation	(3,914)
Effects of change in functional currency	421,094
Balance, ending	211,730
Fair value of embedded derivative liability recognized
Fair value adjustment	(205,450)
Debt Discount [Member]
Short-term Debt [Line Items]
Effects of change in functional currency	(1,500,000)
Balance, beginning
Amortization	300,034
Balance, ending	(1,199,966)
Debt Discount [Member] | July 2020 Convertible Debenture [Member]
Short-term Debt [Line Items]
Effects of change in functional currency
Balance, beginning
Amortization
Balance, ending
Debt Discount [Member] | June 2021 Convertible Debenture [Member]
Short-term Debt [Line Items]
Effects of change in functional currency	(1,500,000)
Balance, beginning
Amortization	300,034
Balance, ending	(1,199,966)
Debt Discount [Member] | July 2021 Convertible Debenture [Member]
Short-term Debt [Line Items]
Effects of change in functional currency
Balance, beginning
Amortization
Balance, ending
Combined Value of Convertible Debenture [Member]
Short-term Debt [Line Items]
Balance, beginning	7,449,807	116,441	116,441
Balance, ending	221,599		7,449,807
Combined Value of Convertible Debenture [Member] | July 2020 Convertible Debenture [Member]
Short-term Debt [Line Items]
Balance, beginning		116,441	116,441
Balance, ending
Combined Value of Convertible Debenture [Member] | June 2021 Convertible Debenture [Member]
Short-term Debt [Line Items]
Balance, beginning	7,449,744
Balance, ending	607		7,449,744
Combined Value of Convertible Debenture [Member] | July 2021 Convertible Debenture [Member]
Short-term Debt [Line Items]
Balance, beginning	63
Balance, ending	$ 220,992		$ 63

CONVERTIBLE DEBENTURE AND DER_3

CONVERTIBLE DEBENTURE AND DERIVATIVE LIABILITY (Details Narrative)	Jan. 31, 2022USD ($)$ / sharesshares	Jan. 31, 2022CAD ($)	Jun. 15, 2021$ / sharesshares	May 18, 2021USD ($)shares	Jan. 31, 2021USD ($)	Jan. 31, 2021CAD ($)	Jul. 31, 2021	Jan. 31, 2022USD ($)$ / sharesshares	Jan. 31, 2022CAD ($)shares	Jan. 31, 2021USD ($)shares	Jan. 31, 2022CAD ($)$ / sharesshares	Nov. 03, 2021$ / sharesshares	Nov. 02, 2021USD ($)	Nov. 02, 2021$ / shares	Oct. 31, 2021USD ($)$ / sharesshares	Jul. 15, 2021USD ($)	Jul. 15, 2021CAD ($)$ / shares	Jun. 15, 2021CAD ($)	Jul. 31, 2020	Jul. 27, 2020USD ($)	Jul. 27, 2020CAD ($)$ / shares	Oct. 31, 2019	Nov. 01, 2016$ / shares
Short-term Debt [Line Items]
Debt, principal amount	$ 53,491							$ 53,491							$ 53,491
Debt instrument, interest rate percentage																						18.00%
Debt host liability share, face value | $ / shares												$ 0.65											$ 0.05
Common stock, shares issued | shares	421,871,770							421,871,770			421,871,770	9,163,425			392,943,398
Common stock, value issued	$ 36,637,228							$ 36,637,228							$ 29,842,167
Debt instrument, conversion price | (per share)			$ 0.10								$ 0.12			$ 0.12	$ 0.10						$ 0.15
Contractual interest	109,808				$ 70,521
Debt conversion, description								(i) one share of the Company’ common stock, (ii) one-half of one Class A common stock purchase warrant, with each whole warrant being exercisable at a price of $0.13 until June 10, 2026, and (iii) one-half of one Class B common stock purchase warrant, with each whole warrant being exercisable at a price of $0.19 until June 10, 2026 (collectively, the “Class A and B Warrants”). In addition, the conversion price for accrued interest is the greater of (i) $0.10 and (ii) the minimum conversion price permitted by the TSX-V at the time of conversion	(i) one share of the Company’ common stock, (ii) one-half of one Class A common stock purchase warrant, with each whole warrant being exercisable at a price of $0.13 until June 10, 2026, and (iii) one-half of one Class B common stock purchase warrant, with each whole warrant being exercisable at a price of $0.19 until June 10, 2026 (collectively, the “Class A and B Warrants”). In addition, the conversion price for accrued interest is the greater of (i) $0.10 and (ii) the minimum conversion price permitted by the TSX-V at the time of conversion
Number of shares issued | shares
Derivative, loss on derivative								$ 11,765,241
Convertible debt combined value	221,599							221,599							$ 7,449,807
Amortization of debt discount premium								300,034
Warrants [Member]
Short-term Debt [Line Items]
Derivative Liability	8,246,718							8,246,718					$ 26,956,177
[custom:ExerciseOfCommonSharePurchaseWarrants]								3,481,052
Broker Warrants [Member]
Short-term Debt [Line Items]
Derivative Liability	41,670							$ 41,670					$ 76,811
Common Stock [Member]
Short-term Debt [Line Items]
Number of shares issued | shares								1,375,499	1,375,499	18,319,388
July 2020 Convertible Debenture [Member]
Short-term Debt [Line Items]
Debt, principal amount																				$ 112,124	$ 150,000
Debt instrument, interest rate percentage																			37.00%	12.00%	12.00%
Debt host liability share, face value | $ / shares																					$ 0.15
Common stock, shares issued | shares				1,360,959
Conversion of stock, shares issued | shares				263,973
Common stock, value issued				$ 26,286
Number of shares issued | shares				1,360,959
Debt instrument, fair value	87,083							$ 87,083
Embedded derivative liability								25,041
July 2021 Convertible Debenture [Member]
Short-term Debt [Line Items]
Debt, principal amount																$ 79,542	$ 100,000
Debt instrument, interest rate percentage																12.00%	12.00%
Debt instrument, conversion price | $ / shares																	$ 0.12
Warrants exerciable price | $ / shares																	$ 0.20
Contractual interest	7,375	$ 9,337			$ 5,802	$ 7,299
Debt instrument interest rate description							effective interest rate of 608.98%
Convertible debenture face value								79,542	$ 100,000
Fair value of embedded derivate liability	421,095							421,095
Beneficial conversion feature additional paid-in capital and loss								341,553	$ 429,400
July 2021 Convertible Debenture [Member] | Convertible Debenture [Member]
Short-term Debt [Line Items]
Debt instrument, fair value	9,262							9,262			$ 11,780
Convertible debt combined value	220,992							220,992			281,080
Fair value of embedded derivate liability	$ 211,730							$ 211,730			269,300
June 2021 Convertible Debenture [Member]
Short-term Debt [Line Items]
Debt, principal amount																		$ 1,500,000
Debt instrument, interest rate percentage																		12.00%
Debt host liability share, face value | $ / shares	$ 1							$ 1
Debt instrument interest rate description					effective interest rate of 1,348%	effective interest rate of 1,348%
Debt instrument maturity date			Dec. 10, 2022
Conversion of convertiable debenture | shares			15,000,000
Number of shares issued | shares								3,000,000	3,000,000
Debt instrument, fair value	$ 1,500,000							$ 1,500,000
Embedded derivative liability								1,646,600
Derivative, loss on derivative								146,601
Convertible debt combined value															$ 7,449,744
Amortization of debt discount premium								300,034
Debt discount carry value								$ 1,199,966
Fair value of embedded derivate liability											$ 529,400
June 2021 Convertible Debenture [Member] | Common Class A [Member]
Short-term Debt [Line Items]
Warrants exerciable price | $ / shares	$ 0.13							$ 0.13
Number of warrants exercisable | shares	1,500,000							1,500,000			1,500,000
June 2021 Convertible Debenture [Member] | Common Class B [Member]
Short-term Debt [Line Items]
Warrants exerciable price | $ / shares	$ 0.19							$ 0.19
Number of warrants exercisable | shares	1,500,000							1,500,000			1,500,000
June 2021 Convertible Debenture [Member] | Common Stock [Member]
Short-term Debt [Line Items]
Number of shares issued | shares								3,000,000	3,000,000

SUMMARY OF CHANGES IN COMMON SH

SUMMARY OF CHANGES IN COMMON SHARE PURCHASE WARRANTS (Details)		3 Months Ended			12 Months Ended
		Jan. 31, 2022$ / sharesshares	Jan. 31, 2022$ / shares$ / sharesshares	Jan. 31, 2021$ / sharesshares	Oct. 31, 2021$ / sharesshares	Oct. 31, 2021$ / sharesshares
Purchase Warrant One [Member]
Class of Warrant or Right [Line Items]
Beinning balance		59,548,982	59,548,982
Granted
Exercised		(15,389,448)	(15,389,448)
Expired/Cancelled		(2,428,363)	(2,428,363)
Ending balance		41,731,171	41,731,171		59,548,982	59,548,982
Weighted average exercise price, beginning | $ / shares			$ 0.22
Weighted average exercise price, granted | $ / shares
Weighted average exercise price, exercised | $ / shares			0.19
Weighted average exercise price, expired/cancelled | $ / shares			0.19
Weighted average exercise price, ending | $ / shares			$ 0.23			$ 0.22
Purchase Warrant Two [Member]
Class of Warrant or Right [Line Items]
Beinning balance
Granted		4,375,499	4,375,499
Exercised
Expired/Cancelled
Ending balance		4,375,499	4,375,499
Weighted average exercise price, beginning | $ / shares
Weighted average exercise price, granted | $ / shares		0.35
Weighted average exercise price, exercised | $ / shares
Weighted average exercise price, ending | $ / shares		$ 0.35
Purchase Warrant [Member]
Class of Warrant or Right [Line Items]
Beinning balance		59,548,982	59,548,982	10,109,642	10,109,642	10,109,642
Granted		4,375,499	4,375,499	18,319,388
Exercised		(15,389,448)	(15,389,448)
Expired/Cancelled		(2,428,363)	(2,428,363)
Ending balance		46,106,670	46,106,670	28,429,030	59,548,982	59,548,982
Weighted average exercise price, beginning | $ / shares				$ 0.11		$ 0.11
Weighted average exercise price, granted | $ / shares						$ 0.19
Weighted average exercise price, exercised | $ / shares
Weighted average exercise price, expired/cancelled | (per share)
Weighted average exercise price, ending | $ / shares				$ 0.16
November 22, 2021 [Member]
Class of Warrant or Right [Line Items]
Expiry Date		Nov. 22, 2021	Nov. 22, 2021	Nov. 22, 2021
Beinning balance		4,160,021	4,160,021
Granted				5,599,171
Exercised		(4,080,573)	(4,080,573)
Expired/Cancelled		(79,448)	(79,448)
Ending balance				5,599,171	4,160,021	4,160,021
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares				$ 0.19
Weighted average life (years)				9 months 18 days
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares			$ 0.19	$ 0.19
January 17, 2022 [Member]
Class of Warrant or Right [Line Items]
Expiry Date		Jan. 17, 2022	Jan. 17, 2022	Jan. 17, 2022
Beinning balance		7,267,914	7,267,914
Granted				7,337,914
Exercised		(5,959,396)	(5,959,396)
Expired/Cancelled		(1,308,518)	(1,308,518)
Ending balance				7,337,914	7,267,914	7,267,914
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares				$ 0.19
Weighted average life (years)				11 months 15 days
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares			$ 0.19	$ 0.19
January 31, 2022 [Member]
Class of Warrant or Right [Line Items]
Expiry Date		Jan. 31, 2022	Jan. 31, 2022	Jan. 31, 2022
Beinning balance		5,382,303	5,382,303
Granted				5,382,303
Exercised		(4,341,906)	(4,341,906)
Expired/Cancelled		(1,040,397)	(1,040,397)
Ending balance				5,382,303	5,382,303	5,382,303
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares				$ 0.19
Weighted average life (years)				11 months 26 days
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares			$ 0.19	$ 0.19
February 21, 2022 [Member]
Class of Warrant or Right [Line Items]
Expiry Date		Feb. 21, 2022	Feb. 21, 2022	Feb. 21, 2022
Beinning balance		1,505,200	1,505,200	1,505,200	1,505,200	1,505,200
Granted
Exercised
Expired/Cancelled
Ending balance		1,505,200	1,505,200	1,505,200	1,505,200	1,505,200
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares				$ 0.05
Weighted average life (years)		21 days	21 days	1 year 21 days
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares			$ 0.05	$ 0.05
March 24, 2022 [Member]
Class of Warrant or Right [Line Items]
Expiry Date		Mar. 24, 2022	Mar. 24, 2022
Beinning balance		6,341,872	6,341,872
Granted
Exercised		(570,046)	(570,046)
Expired/Cancelled
Ending balance		5,771,826	5,771,826		6,341,872	6,341,872
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares
Weighted average life (years)		1 month 20 days	1 month 20 days
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares			$ 0.19
March 27, 2022 [Member]
Class of Warrant or Right [Line Items]
Expiry Date		Mar. 27, 2022	Mar. 27, 2022	Mar. 27, 2022
Beinning balance		982,025	982,025	1,482,025	1,482,025	1,482,025
Granted
Exercised
Expired/Cancelled
Ending balance		982,025	982,025	1,482,025	982,025	982,025
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares				$ 0.05
Weighted average life (years)		1 month 24 days	1 month 24 days	1 year 1 month 24 days
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares			$ 0.05	$ 0.05
April 27, 2022 [Member]
Class of Warrant or Right [Line Items]
Expiry Date		Apr. 27, 2022	Apr. 27, 2022
Beinning balance		791,395	791,395
Granted
Exercised		(50,000)	(50,000)
Expired/Cancelled
Ending balance		741,395	741,395		791,395	791,395
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares
Weighted average life (years)		2 months 26 days	2 months 26 days
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares			$ 0.19
May 9, 2022 [Member]
Class of Warrant or Right [Line Items]
Expiry Date		May 9, 2022	May 9, 2022	May 9, 2022
Beinning balance		1,813,725	1,813,725	2,368,626	2,368,626	2,368,626
Granted
Exercised
Expired/Cancelled
Ending balance		1,813,725	1,813,725	2,368,626	1,813,725	1,813,725
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares				$ 0.05
Weighted average life (years)		3 months 7 days	3 months 7 days	1 year 3 months 7 days
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares			$ 0.05	$ 0.05
May 30, 2022 [Member]
Class of Warrant or Right [Line Items]
Expiry Date		May 30, 2022	May 30, 2022
Beinning balance		5,223,420	5,223,420
Granted
Exercised		(47,527)	(47,527)
Expired/Cancelled
Ending balance		5,175,893	5,175,893		5,223,420	5,223,420
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares
Weighted average life (years)		3 months 29 days	3 months 29 days
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares			$ 0.19
June 17, 2022 [Member]
Class of Warrant or Right [Line Items]
Expiry Date		Jun. 17, 2022	Jun. 17, 2022
Beinning balance		17,703,506	17,703,506
Granted
Exercised		(110,000)	(110,000)
Expired/Cancelled
Ending balance		17,593,506	17,593,506		17,703,506	17,703,506
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares
Weighted average life (years)		4 months 17 days	4 months 17 days
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares			$ 0.19
July 18, 2022 [Member]
Class of Warrant or Right [Line Items]
Expiry Date		Jul. 18, 2022	Jul. 18, 2022
Beinning balance		4,350,000	4,350,000
Granted
Exercised		(30,000)	(30,000)
Expired/Cancelled
Ending balance		4,320,000	4,320,000		4,350,000	4,350,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares
Weighted average life (years)		5 months 15 days	5 months 15 days
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares			$ 0.30
August 14, 2022 [Member]
Class of Warrant or Right [Line Items]
Expiry Date		Aug. 14, 2022	Aug. 14, 2022	Aug. 14, 2022
Beinning balance		200,000	200,000	1,110,000	1,110,000	1,110,000
Granted
Exercised		(200,000)	(200,000)
Expired/Cancelled
Ending balance				1,110,000	200,000	200,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares				$ 0.05
Weighted average life (years)		6 months 10 days	6 months 10 days	1 year 6 months 10 days
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares			$ 0.05	$ 0.05
February 13, 2023 [Member]
Class of Warrant or Right [Line Items]
Expiry Date		Feb. 13, 2023	Feb. 13, 2023
Beinning balance		3,827,601	3,827,601
Granted
Exercised
Expired/Cancelled
Ending balance		3,827,601	3,827,601		3,827,601	3,827,601
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares
Weighted average life (years)		1 year 14 days	1 year 14 days
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares			$ 0.65
November 27, 2022 [Member]
Class of Warrant or Right [Line Items]
Expiry Date		Nov. 27, 2022	Nov. 27, 2022
Beinning balance
Granted		1,375,499	1,375,499
Exercised
Expired/Cancelled
Ending balance		1,375,499	1,375,499
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares		$ 0.75	$ 0.75
Weighted average life (years)		9 months 25 days	9 months 25 days
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares		$ 0.75
June 10, 2026 [Member]
Class of Warrant or Right [Line Items]
Expiry Date		Jun. 10, 2026	Jun. 10, 2026
Beinning balance
Granted		1,500,000	1,500,000
Exercised
Expired/Cancelled
Ending balance		1,500,000	1,500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares		$ 0.13	$ 0.13
Weighted average life (years)		4 years 4 months 9 days	4 years 4 months 9 days
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares		$ 0.13
June 10, 2026 One [Member]
Class of Warrant or Right [Line Items]
Expiry Date		Jun. 10, 2026	Jun. 10, 2026
Beinning balance
Granted		1,500,000	1,500,000
Exercised
Expired/Cancelled
Ending balance		1,500,000	1,500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares		$ 0.19	$ 0.19
Weighted average life (years)		4 years 4 months 9 days	4 years 4 months 9 days
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares		$ 0.19
August 31, 2021 [Member]
Class of Warrant or Right [Line Items]
Expiry Date				Aug. 31, 2021
Beinning balance				3,643,791	3,643,791	3,643,791
Granted
Exercised
Expired/Cancelled
Ending balance				3,643,791
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares	[1]			$ 0.21
Weighted average life (years)				6 months 29 days
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares	[1]			$ 0.21
[1]	The Company received approval of the TSX-V on January 13, 2021 and amended the expiry date of 3,643,791 extending the expiry date from January 17, 2021 to August 31, 2021 0.30 10

SUMMARY OF CHANGES IN COMMON _2

SUMMARY OF CHANGES IN COMMON SHARE PURCHASE WARRANTS (Details) (Parenthetical)	Jan. 13, 2021Days$ / sharesshares	Jan. 31, 2022$ / shares	Oct. 31, 2021$ / shares
Equity [Abstract]
Class of Warrant or Right, Outstanding | shares	3,643,791
Maturity date, description	extending the expiry date from January 17, 2021 to August 31, 2021
Common Stock, Par or Stated Value Per Share | (per share)	$ 0.30	$ 0.001	$ 0.001
Number of minimum consecutive trading days | Days	10

SCHEDULE OF ASSUMPTIONS USED (D

SCHEDULE OF ASSUMPTIONS USED (Details) - $ / shares	Jan. 31, 2022	Nov. 02, 2021	Oct. 31, 2021	Jun. 15, 2021	Jul. 27, 2020	Oct. 31, 2021	Jan. 31, 2022	Oct. 31, 2021
Risk free rate of interest	1.51%	1.07%	1.08%	0.31%	0.26%		1.34%
Risk free rate of interest, minimum								0.20%
Risk free rate of interest, maximum								1.07%
Expected life of options	5 months 12 days	8 months 12 days		1 year 6 months	8 months 26 days	1 year 1 month 9 days	5 years
Exercise price of options	$ 0.58						$ 0.58
Expected annualized volatility	109.11%	124.34%	107.62%	87.17%	82.54%		136.08%
Expected annualized volatility, minimum								130.88%
Expected annualized volatility, maximum								140.05%
Expected dividend rate
Minimum [Member]
Expected life of options								2 years
Exercise price of options			$ 0.13			$ 0.13		$ 0.13
Maximum [Member]
Expected life of options								5 years
Exercise price of options			$ 0.70			$ 0.70		$ 0.70

SCHEDULE OF STOCK OPTIONS ACTIV

SCHEDULE OF STOCK OPTIONS ACTIVITY (Details)	3 Months Ended				12 Months Ended
	Jan. 31, 2022USD ($)shares	Jan. 31, 2022$ / shares	Jan. 31, 2021USD ($)shares	Jan. 31, 2021$ / shares	Oct. 31, 2021USD ($)shares	Oct. 31, 2021$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total outstanding, beginning balance	61,260,000		28,420,000		28,420,000
Total granted	250,000		15,650,000
Total exercised
Total exprired, cancelled	(2,000,000)		(800,000)
Total outstanding, ending balance	59,510,000		43,270,000		61,260,000
Total vested	59,285,000		42,432,500
Weighted average remaining life, outstanding	3 years 3 months 7 days		3 years 2 months 23 days
Weighted average exercise price, beginning balance | $ / shares		$ 0.33		$ 0.09		$ 0.09
Weighted average exercise price, granted | $ / shares		0.58		0.13
Weighted average exercise price, exercised | $ / shares
Weighted average exercise price, expired/cancelled | $ / shares		0.07		0.13
Weighted average exercise price, ending balance | $ / shares		0.34		0.10		0.33
Weighted average exercise price, vested | $ / shares		0.33		0.10
Aggregate intrinsic value, outstanding | $	$ 19,994,025		$ 801,922		$ 801,922
Aggregate intrinsic value, outstanding | $	4,886,548		743,918		$ 19,994,025
Aggregate intrinsic value, vested | $	$ 493,542		$ 801,892
Weighted average remaining life, outstanding	3 years 5 months 15 days		3 years 2 months 4 days
Weighted average remaining life, vested	3 years 3 months 3 days		3 years 2 months 26 days
Weighted average exercise price, ending balance | $ / shares		0.34		0.10		$ 0.33
Option One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date	Mar. 27, 2022		Feb. 11, 2021
Share Price | $ / shares		0.05		0.05
Total outstanding, beginning balance	1,500,000		800,000		800,000
Total granted
Total exercised
Total exprired, cancelled	(250,000)
Total outstanding, ending balance	1,250,000		800,000		1,500,000
Total vested	1,250,000		800,000
Weighted average remaining life, outstanding	1 month 24 days		10 days
Option Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date	Dec. 30, 2022		Aug. 16, 2021
Share Price | $ / shares		0.13		0.05
Total outstanding, beginning balance	6,000,000		600,000		600,000
Total granted
Total exercised
Total exprired, cancelled
Total outstanding, ending balance	6,000,000		600,000		6,000,000
Total vested	6,000,000		600,000
Weighted average remaining life, outstanding	10 months 28 days		6 months 14 days
Option Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date	Aug. 12, 2023		Mar. 27, 2022
Share Price | $ / shares		0.05		0.05
Total outstanding, beginning balance	2,290,000		1,750,000		1,750,000
Total granted
Total exercised
Total exprired, cancelled	(750,000)
Total outstanding, ending balance	1,540,000		1,750,000		2,290,000
Total vested	1,540,000		1,750,000
Weighted average remaining life, outstanding	1 year 6 months 10 days		1 year 1 month 24 days
Option Four [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date	Dec. 3, 2023		Aug. 26, 2022
Share Price | $ / shares		0.05		0.13
Total outstanding, beginning balance	6,450,000		500,000		500,000
Total granted
Total exercised
Total exprired, cancelled	(500,000)		(500,000)
Total outstanding, ending balance	5,950,000				6,450,000
Total vested	5,950,000
Weighted average remaining life, outstanding	1 year 10 months 2 days
Option Five [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date	May 22, 2024		Dec. 30, 2022
Share Price | $ / shares		0.12		0.13
Total outstanding, beginning balance	7,900,000
Total granted			6,150,000
Total exercised
Total exprired, cancelled	(500,000)
Total outstanding, ending balance	7,400,000		6,150,000		7,900,000
Total vested	7,400,000		5,500,000
Weighted average remaining life, outstanding	2 years 3 months 21 days		1 year 10 months 28 days
Option Six [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date	Nov. 3, 2024		Apr. 19, 2023
Share Price | $ / shares		0.15		0.05
Total outstanding, beginning balance	700,000		800,000		800,000
Total granted
Total exercised
Total exprired, cancelled
Total outstanding, ending balance	700,000		800,000		700,000
Total vested	700,000		800,000
Weighted average remaining life, outstanding	2 years 9 months 3 days		2 years 2 months 15 days
Option Seven [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date	Nov. 24, 2024		Aug. 12, 2023
Share Price | $ / shares		0.16		0.05
Total outstanding, beginning balance	320,000		3,120,000		3,120,000
Total granted
Total exercised
Total exprired, cancelled
Total outstanding, ending balance	320,000		3,120,000		320,000
Total vested	320,000		3,120,000
Weighted average remaining life, outstanding	2 years 9 months 25 days		2 years 6 months 10 days
Option Eight [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date	Mar. 26, 2025		Dec. 3, 2023
Share Price | $ / shares		0.11		0.05
Total outstanding, beginning balance	100,000		7,000,000		7,000,000
Total granted
Total exercised
Total exprired, cancelled
Total outstanding, ending balance	100,000		7,000,000		100,000
Total vested	100,000		7,000,000
Weighted average remaining life, outstanding	3 years 1 month 24 days		2 years 10 months 2 days
Option Nine [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date	Apr. 23, 2025		May 22, 2024
Share Price | $ / shares		0.12		0.12
Total outstanding, beginning balance	3,350,000		7,950,000		7,950,000
Total granted
Total exercised
Total exprired, cancelled
Total outstanding, ending balance	3,350,000		7,950,000		3,350,000
Total vested	3,350,000		7,950,000
Weighted average remaining life, outstanding	3 years 2 months 23 days		3 years 3 months 21 days
Option Ten [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date	Dec. 30, 2025		Nov. 3, 2024
Share Price | $ / shares		0.13		0.15
Total outstanding, beginning balance	9,500,000		700,000		700,000
Total granted
Total exercised
Total exprired, cancelled
Total outstanding, ending balance	9,500,000		700,000		9,500,000
Total vested	9,500,000		700,000
Weighted average remaining life, outstanding	3 years 11 months 1 day		3 years 9 months 3 days
Option Eleven [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date	Aug. 30, 2026		Nov. 24, 2024
Share Price | $ / shares		0.70		0.16
Total outstanding, beginning balance	21,700,000		900,000		900,000
Total granted
Total exercised
Total exprired, cancelled
Total outstanding, ending balance	21,700,000		900,000		21,700,000
Total vested	21,475,000		900,000
Weighted average remaining life, outstanding	4 years 6 months 29 days		3 years 9 months 25 days
Option Twelve [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date	Oct. 1, 2026		Mar. 26, 2025
Share Price | $ / shares		0.50		0.11
Total outstanding, beginning balance	1,450,000		300,000		300,000
Total granted
Total exercised
Total exprired, cancelled
Total outstanding, ending balance	1,450,000		300,000		1,450,000
Total vested	1,450,000		300,000
Weighted average remaining life, outstanding	4 years 8 months 1 day		4 years 1 month 24 days
Option Thirteen [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date	Dec. 3, 2026		Apr. 23, 2025
Share Price | $ / shares		$ 0.58		0.12
Total outstanding, beginning balance			4,000,000		4,000,000
Total granted	250,000
Total exercised
Total exprired, cancelled			(300,000)
Total outstanding, ending balance	250,000		3,700,000
Total vested	250,000		3,512,500
Weighted average remaining life, outstanding	4 years 10 months 2 days		4 years 2 months 23 days
Option Fourteen [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date			Dec. 30, 2025
Share Price | $ / shares				$ 0.13
Total outstanding, beginning balance
Total granted			9,500,000
Total exercised
Total exprired, cancelled
Total outstanding, ending balance			9,500,000
Total vested			9,500,000
Weighted average remaining life, outstanding			4 years 11 months 1 day

SCHEDULE OF NONVESTED STOCK OPT

SCHEDULE OF NONVESTED STOCK OPTIONS (Details)	3 Months Ended		12 Months Ended
	Jan. 31, 2022USD ($)$ / sharesshares	Jan. 31, 2022$ / shares	Oct. 31, 2021$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant date fair value per option, granted | $ / shares
Total nonvested, beginning balance	462,500
Total nonvested, granted
Total nonvested, vested	(237,500)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares
Total nonvested, ending balance	225,000		462,500
Total nonvested, expired, cancelled
Weighted average grant date fair value per option, beginning balance | $ / shares		0.39
Weighted average grant date fair value per option, vested | $ / shares		0.22
Weighted average grant date fair value per option, expired, cancelled | $ / shares
Weighted average grant date fair value per option, ending balance | $ / shares		0.56	$ 0.39
Weighted average grant date fair value total, beginning balance | $	$ 144,131
Weighted average grant date fair value total, granted | $
Weighted average grant date fair value total, vested | $	$ 41,571
Weighted average grant date fair value total, expired, cancelled | $ / shares
Weighted average grant date fair value total, ending balance | $	$ 98,764
Option One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Non vested Expiration Date	Dec. 30, 2022
Weighted average grant date fair value per option, granted | $ / shares		0.07
Total nonvested, beginning balance	162,500
Total nonvested, granted
Total nonvested, vested	(162,500)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares
Total nonvested, ending balance			162,500
Weighted average life (years)	1 year 1 month 28 days
Total nonvested, expired, cancelled
Option Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Non vested Expiration Date	Aug. 30, 2026
Weighted average grant date fair value per option, granted | $ / shares		$ 0.56
Total nonvested, beginning balance	300,000
Total nonvested, granted
Total nonvested, vested	(75,000)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares
Total nonvested, ending balance	225,000		300,000
Weighted average life (years)	4 years 9 months 29 days
Total nonvested, expired, cancelled

SHARE CAPITAL (Details Narrativ

SHARE CAPITAL (Details Narrative)	Jan. 20, 2022USD ($)$ / sharesshares	Dec. 13, 2021$ / sharesshares	Dec. 03, 2021$ / sharesshares	Nov. 26, 2021USD ($)$ / sharesshares	Nov. 04, 2021$ / sharesshares	Oct. 01, 2021$ / sharesshares	Aug. 30, 2021$ / sharesshares	Aug. 11, 2021USD ($)$ / sharesshares	Aug. 11, 2021CAD ($)shares	Jul. 16, 2021USD ($)shares	Jul. 16, 2021CAD ($)$ / sharesshares	Jun. 17, 2021USD ($)shares	Jun. 17, 2021CAD ($)$ / sharesshares	Jun. 07, 2021USD ($)shares	May 28, 2021USD ($)shares	May 28, 2021CAD ($)$ / sharesshares	May 18, 2021USD ($)shares	May 05, 2021USD ($)	Apr. 27, 2021USD ($)shares	Apr. 27, 2021CAD ($)shares	Mar. 24, 2021USD ($)shares	Mar. 24, 2021CAD ($)$ / sharesshares	Jan. 29, 2021USD ($)shares	Jan. 29, 2021CAD ($)$ / sharesshares	Jan. 15, 2021USD ($)shares	Jan. 15, 2021CAD ($)shares	Dec. 30, 2020$ / sharesshares	Nov. 20, 2020USD ($)shares	Nov. 20, 2020CAD ($)$ / sharesshares	Aug. 08, 2018	Jan. 31, 2022CAD ($)	Jan. 31, 2022USD ($)$ / sharesshares	Jan. 31, 2022CAD ($)$ / sharesshares	Jan. 31, 2021USD ($)shares	Oct. 31, 2021USD ($)$ / sharesshares	Oct. 31, 2021CAD ($)$ / sharesshares	Jan. 31, 2022$ / shares	Nov. 03, 2021USD ($)shares	Nov. 03, 2021CAD ($)$ / sharesshares	Oct. 31, 2021$ / shares	Aug. 11, 2021$ / shares	Jun. 11, 2021shares	Jun. 07, 2021CAD ($)$ / shares	May 05, 2021$ / shares	Apr. 24, 2021$ / shares	Feb. 08, 2021shares	Jan. 15, 2021$ / shares	Jan. 13, 2021$ / shares	Jul. 27, 2020$ / shares	Aug. 29, 2018USD ($)	Nov. 01, 2016$ / shares
Subsidiary, Sale of Stock [Line Items]
Common voting shares																																1,000,000,000			1,000,000,000
Common stock par value | (per share)																																$ 0.001			$ 0.001													$ 0.30
Number of shares issued
Common shares price per share | $ / shares																																							$ 0.65												$ 0.05
Common stock shares subscriptions | $																																$ 46,741			$ 209,827
Fair value of assets																																						$ 4,796,832	$ 5,956,226
Common stock shares issued																																421,871,770			392,943,398			9,163,425	9,163,425
Number of stock options granted																																250,000	250,000	15,650,000
Common Stock, Value, Issued | $																																$ 36,637,228			$ 29,842,167
Proceeds from Issuance of Common Stock | $																																$ 2,804,182		$ 1,256,934
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant																																7,642,368
Share-based Payment Arrangement, Noncash Expense | $																																$ 131,575		1,048,990
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares
Intrinsic value of options exercised | $
Antidilutive securities excluded from computation of earnings per share amount																																105,616,670	105,616,670		120,808,982	120,808,982
2017 Stock Option Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Number of stock options granted																											15,650,000
Options exercisable price | $ / shares																											$ 0.13
Stock option granted terms																														Stock options granted are subject to a maximum term of 5 years. All options granted shall vest immediately, except for those options granted to persons performing investor relations activities for the Company
2017 Stock Option Plan [Member] | Exercisable at Five Years [Member]
Subsidiary, Sale of Stock [Line Items]
Number of stock options exercisable																											9,500,000
2017 Stock Option Plan [Member] | Exercisable at Two Years [Member]
Subsidiary, Sale of Stock [Line Items]
Number of stock options exercisable																											6,150,000
2021 Equity Incentive Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Number of stock options granted			250,000			1,450,000	21,700,000
Options exercisable price | $ / shares			$ 0.58			$ 0.50	$ 0.70
Number of shares authorized to issued																																3,730,000										27,312,368
Number of stock options forfeited																																			1,730,000	1,730,000
Options exercisable period			5 years			5 years	5 years
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant																																31,042,368
Class A Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Exercise of warrants price per share | $ / shares	$ 0.13	$ 0.13			$ 0.13
Shares purchase of warrants		500,000			500,000
Class B Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issuance costs | $	$ 1,361
Exercise of warrants price per share | $ / shares	$ 0.19	$ 0.19			$ 0.19
Shares purchase of warrants	500,000	500,000			500,000
Equity Option [Member]
Subsidiary, Sale of Stock [Line Items]
Number of stock options granted																																			2,630,000	2,630,000
Proceeds from stock options erercised																																			$ 140,734	$ 175,800
Proceeds from Other Equity | $																																			$ 121,932
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares																																	$ 0.50			$ 0.09
Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock shares issued																																			7,014,969
Proceeds from stock warrants erercised																																			$ 887,520	$ 1,120,130
Common stock warrants expired unexercised																																			525,173
Proceeds from Other Equity | $																																			$ 4,291
Warrants unexercised																																2,428,363
Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued																																1,375,499	1,375,499	18,319,388
Stock Issued During Period, Shares, Conversion of Convertible Securities	1,000,000	1,000,000			1,000,000																											3,000,000	3,000,000
Proceeds from Issuance of Common Stock																															$ 2,899,295	$ 2,293,946
Warrants unexercised																																15,389,448
Common Stock One [Member]
Subsidiary, Sale of Stock [Line Items]
Common shares price per share | $ / shares																																					$ 0.19
Shares purchase of warrants																																15,159,448
Proceeds from Issuance of Common Stock																																$ 2,279,136	$ 2,880,295
Common Stock Two [Member]
Subsidiary, Sale of Stock [Line Items]
Common shares price per share | $ / shares																																					0.05
Shares purchase of warrants																																200,000
Proceeds from Issuance of Common Stock																																$ 7,830	10,000
Common Stock Three [Member]
Subsidiary, Sale of Stock [Line Items]
Common shares price per share | $ / shares																																					$ 0.30
Shares purchase of warrants																																30,000
Proceeds from Issuance of Common Stock																																$ 6,981	$ 9,000
Equipment [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued														1,538,461
Common shares price per share | $ / shares																																											$ 0.24
Fair value of assets														$ 305,832																													$ 369,231
July 2020 Convertible Debenture [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued																	1,360,959
Common shares price per share | $ / shares																																																	$ 0.15
Convertiable common shares																	263,973
Conversion of stock value | $																	$ 26,286
Common stock shares issued																	1,360,959
Common Stock, Value, Issued | $																	$ 26,286
June 2021 Convertible Debentures [Member]
Subsidiary, Sale of Stock [Line Items]
Stock Issued During Period, Shares, Conversion of Units	1,000,000	1,000,000			1,000,000
Maximum [Member]
Subsidiary, Sale of Stock [Line Items]
Shares purchase of warrants																																														33,000,000
Maximum [Member] | 2017 Stock Option Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Percentage of authorized grant stock options																														20.00%
Maximum [Member] | Director and Officers [Member]
Subsidiary, Sale of Stock [Line Items]
Common Stock, Value, Issued | $																																																		$ 5,000,000
Maximum [Member] | Equity Option [Member]
Subsidiary, Sale of Stock [Line Items]
Options exercisable price | $ / shares																																								$ 0.16
Maximum [Member] | Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Exercise of warrants price per share | $ / shares																																								0.21
Minimum [Member] | Equity Option [Member]
Subsidiary, Sale of Stock [Line Items]
Options exercisable price | $ / shares																																								0.05
Minimum [Member] | Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Exercise of warrants price per share | $ / shares																																								0.05
Non Brokered Private Placement [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued								3,827,601	3,827,601	4,350,000	4,350,000																								25,724,955	25,724,955
Common shares price per share | (per share)								$ 0.44			$ 0.20																													0.13	$ 0.55			$ 0.13
Proceeds from issuance of private placement								$ 1,683,336	$ 2,105,180	$ 690,860	$ 870,000																								$ 2,621,314	$ 3,344,244
Issuance of shares, description								Each unit consists of one common share and one common share purchase warrant entitling the holder thereof to acquire a further common share at a price of CA$0.65 (US$0.52) for a period of eighteen months from the date of closing	Each unit consists of one common share and one common share purchase warrant entitling the holder thereof to acquire a further common share at a price of CA$0.65 (US$0.52) for a period of eighteen months from the date of closing	Each unit consists of one common share and one common share purchase warrant entitling the holder thereof to acquire a further common share at a price of CA$0.30 for a period of one year from the date of closing	Each unit consists of one common share and one common share purchase warrant entitling the holder thereof to acquire a further common share at a price of CA$0.30 for a period of one year from the date of closing																								Each unit issued consists of one common share and one common share purchase warrant entitling the holder to acquire a further common share at a price of CA$0.19 for a period of one year from the closing date of the respective financing tranche	Each unit issued consists of one common share and one common share purchase warrant entitling the holder to acquire a further common share at a price of CA$0.19 for a period of one year from the closing date of the respective financing tranche
Shares issuance costs | $								$ 124,923		$ 48,319																									$ 195,614
Non Brokered Private Placement [Member] | Maximum [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from issuance of private placement | $																		$ 3,000,000
Non Brokered Private Placement [Member] | Share-based Payment Arrangement, Tranche One [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued															5,223,420	5,223,420												5,599,171	5,599,171
Common shares price per share | $ / shares																$ 0.13													$ 0.13
Proceeds from issuance of private placement															$ 561,844	$ 679,044												$ 556,876	$ 727,892
Non Brokered Private Placement [Member] | Share-based Payment Arrangement, Tranche Two [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued																									7,337,914	7,337,914
Common shares price per share | $ / shares																																															$ 0.13
Proceeds from issuance of private placement																									$ 749,435	$ 953,930
Common stock shares subscriptions | $																									$ 39,996
Non Brokered Private Placement [Member] | Share-based Payment Arrangement, Tranche Three [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued																							5,382,303	5,382,303
Common shares price per share | $ / shares																								$ 0.13
Proceeds from issuance of private placement																							$ 547,496	$ 699,699
Non Brokered Private Placement [Member] | Share Based Compensation Award Tranche Four [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued																					6,554,172	6,554,172
Common shares price per share | $ / shares																						$ 0.13
Proceeds from issuance of private placement																					$ 678,270	$ 852,042
Non Brokered Private Placement [Member] | Share Based Compensation Award Tranche Five and Final [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued																			851,395	851,395
Common shares price per share | $ / shares																																													$ 0.13
Proceeds from issuance of private placement																			$ 89,237	$ 110,681
Non Brokered Private Placement [Member] | Share Based Compensation Award Tranche Two and Final [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued												17,853,506	17,853,506
Common shares price per share | $ / shares													$ 0.13
Proceeds from issuance of private placement												$ 1,880,687	$ 2,320,956
Non Brokered Private Placement One [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued																																			23,076,926	23,076,926
Common shares price per share | $ / shares																																								$ 0.13
Proceeds from issuance of private placement																																			$ 2,442,531	$ 3,000,000
Issuance of shares, description																																			Each unit issued consists of one common share and one common share purchase warrant entitling the holder thereof to acquire a further common share at a price of CA$0.19 for a period of one year from the date of closing of the respective financing tranche	Each unit issued consists of one common share and one common share purchase warrant entitling the holder thereof to acquire a further common share at a price of CA$0.19 for a period of one year from the date of closing of the respective financing tranche
Shares issuance costs | $																																			$ 154,336
Private Placement [Member] | Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issued				1,375,499
Common shares price per share | $ / shares				$ 0.55
Proceeds from issuance of private placement | $				$ 756,524
Shares issuance costs | $				$ 26,656
Share Price | $ / shares				$ 0.75

CAPITAL MANAGEMENT (Details Nar

CAPITAL MANAGEMENT (Details Narrative) - USD ($)	Jan. 31, 2022	Oct. 31, 2021	Jan. 31, 2021	Oct. 31, 2020
Capital Management
Stockholders equity	$ 7,422,277	$ 6,770,038	$ 1,984,751	$ 2,079,903

SCHEDULE OF CLASSIFICATION OF I

SCHEDULE OF CLASSIFICATION OF ITS FINANCIAL INSTRUMENTS (Details)	Jan. 31, 2022USD ($)
Fair Value Disclosures [Abstract]
Cash	$ 772,522
Amounts receivable	235,821
Deposits held by related parties	565,741
Accounts payable and accrued liabilities	2,552,509
Due to related parties	1,092,786
Convertible debenture	221,599
Derivative liability warrants	$ 8,288,387

SCHEDULE OF FOREIGN CURRENCY RI

SCHEDULE OF FOREIGN CURRENCY RISK (Details)	Jan. 31, 2022CAD ($)
Total	$ (2,242,043)
Cash [Member]
Total	498,538
Amounts receivable [Member]
Total	299,940
Accounts Payable and Accrued Liabilities [Member]
Total	(2,210,900)
Due To Related Parties [Member]
Total	(729,621)
Convertible Debenture [Member]
Total	$ (100,000)

FINANCIAL INSTRUMENTS AND FIN_3

FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (Details Narrative) - USD ($)	3 Months Ended
	Jan. 31, 2022	Oct. 31, 2021
Fair Value Disclosures [Abstract]
Cash	$ 772,522	$ 462,360
Short term investments	0	0
Foreign currency risk rate
Increase decrease in foreign currency transaction amount	88,138
Working capital deficit	$ 10,900,774	$ 9,657,316

SCHEDULE OF ASSETS INFORMATION

SCHEDULE OF ASSETS INFORMATION (Details) - USD ($)	Jan. 31, 2022	Oct. 31, 2021	Oct. 31, 2020
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment	$ 3,159,244	$ 2,574,704	$ 79,436
Property, plant, equipment and mineral properties	93,453	93,453
Assets	3,252,696	2,668,157
Other assets	2,247,801	1,845,355
Total Assets	5,500,498	4,513,512
CANADA
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment	3,128,142	2,546,383
Other assets	838,067	1,554,827
UNITED STATES
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment	31,101	28,321
Property, plant, equipment and mineral properties	93,453	93,453
Other assets	$ 1,409,734	$ 290,528

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative)

Mar. 10, 2022$ / sharesshares

Jan. 20, 2022$ / sharesshares

Dec. 13, 2021$ / sharesshares

Dec. 03, 2021$ / sharesshares

Nov. 04, 2021$ / sharesshares

Oct. 01, 2021$ / sharesshares

Aug. 30, 2021$ / sharesshares

Mar. 15, 2022CAD ($)$ / sharesshares

Jan. 31, 2022CAD ($)

Jan. 31, 2022USD ($)shares

Jan. 31, 2021USD ($)shares

Nov. 03, 2021$ / shares

Nov. 01, 2016$ / shares

Subsequent Event [Line Items]

Shares issued pursuant to private placements, shares

Number of shares issued price per share | $ / shares

$ 0.65

$ 0.05

Proceeds from issuance of common stock | $

$ 2,804,182

$ 1,256,934

Incentive stock options granted

250,000

15,650,000

2021 Equity Incentive Plan [Member]

Subsequent Event [Line Items]

Incentive stock options granted

250,000

1,450,000

21,700,000

Options exercisable price | $ / shares

$ 0.58

$ 0.50

$ 0.70

Options exercisable term

5 years

5 years

5 years

Class A Warrants [Member]

Subsequent Event [Line Items]

Purchase of warrants

500,000

500,000

Warrants exerciable price | $ / shares

$ 0.13

$ 0.13

$ 0.13

Class B Warrants [Member]

Subsequent Event [Line Items]

Purchase of warrants

500,000

500,000

500,000

Warrants exerciable price | $ / shares

$ 0.19

$ 0.19

$ 0.19

Common Stock [Member]

Subsequent Event [Line Items]

Stock issued during period, conversion shares

1,000,000

1,000,000

1,000,000

3,000,000

Shares issued pursuant to private placements, shares

1,375,499

18,319,388

Proceeds from issuance of common stock

$ 2,899,295

$ 2,293,946

June 2021 Convertible Debentures [Member]

Subsequent Event [Line Items]

Stock issued during period, conversion units

1,000,000

1,000,000

1,000,000

Subsequent Event [Member] | 2021 Equity Incentive Plan [Member]

Subsequent Event [Line Items]

Incentive stock options granted

500,000

Options exercisable price | $ / shares

$ 0.40

Options exercisable term

5 years

Subsequent Event [Member] | Class A Warrants [Member]

Subsequent Event [Line Items]

Purchase of warrants

500,000

Warrants exerciable price | $ / shares

$ 0.13

Subsequent Event [Member] | Class B Warrants [Member]

Subsequent Event [Line Items]

Purchase of warrants

500,000

Warrants exerciable price | $ / shares

$ 0.19

Subsequent Event [Member] | Common Stock [Member]

Subsequent Event [Line Items]

Stock issued during period, conversion shares

1,000,000

Subsequent Event [Member] | Common Stock Purchase Warrant [Member]

Subsequent Event [Line Items]

Shares issued pursuant to private placements, shares

1,793,657

Number of shares issued price per share | $ / shares

$ 0.19

Proceeds from issuance of common stock | $

$ 340,795

Common stock warrants expired unexercised

1,305,200

Subsequent Event [Member] | Common Stock Purchase Warrant One [Member]

Subsequent Event [Line Items]

Shares issued pursuant to private placements, shares

1,082,025

Number of shares issued price per share | $ / shares

$ 0.05

Proceeds from issuance of common stock | $

$ 54,101

Subsequent Event [Member] | June 2021 Convertible Debentures [Member]

Subsequent Event [Line Items]

Stock issued during period, conversion units

1,000,000